CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | EC 5.3.* (intramolecular oxidoreductase) inhibitor |
|
Accession: | CHEBI:76694
|
browse the term
|
Definition: | An isomerase inhibitor that interferes with the action of an intramolecular oxidoreductase (EC 5.3.*.*). |
Synonyms: | related_synonym: | intramolecular oxidoreductase (EC 5.3.*) inhibitors; intramolecular oxidoreductase inhibitor; intramolecular oxidoreductase inhibitors |
|
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
multiple interactions |
EXP |
amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA] |
CTD |
PMID:23688403 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
EXP |
amorolfine inhibits the reaction [Biological Products results in increased expression of CXCL10 mRNA]; amorolfine inhibits the reaction [Biological Products results in increased expression of CXCL10 protein] |
CTD |
PMID:24471457 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions |
EXP |
amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CXCL8 mRNA] |
CTD |
PMID:23688403 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
IL4 |
interleukin 4 |
multiple interactions |
EXP |
4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of 15-deoxy-delta(12,14)-prostaglandin J2]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of Prostaglandin D2]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein]]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of 15-deoxy-delta(12,14)-prostaglandin J2]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in decreased secretion of Prostaglandin D2]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased degradation of NFKBIA protein]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CCL5 mRNA]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of CXCL8 mRNA]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Thromboxane B2]; amorolfine promotes the reaction [[Poly I-C co-treated with IL4 protein] results in increased secretion of Dinoprostone] |
CTD |
PMID:23688403 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
KCNH2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
EXP |
amorolfine results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
EXP |
amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased degradation of NFKBIA protein] |
CTD |
PMID:23688403 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
multiple interactions |
EXP |
amorolfine inhibits the reaction [Biological Products results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:24471457 |
|
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
|
|
G |
TSLP |
thymic stromal lymphopoietin |
multiple interactions |
EXP |
4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]]; 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine inhibits the reaction [amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein]]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP mRNA]; amorolfine inhibits the reaction [[Poly I-C co-treated with IL4 protein] results in increased expression of TSLP protein] |
CTD |
PMID:23688403 |
|
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
|
|
|
G |
AASDHPPT |
aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase |
decreases expression |
EXP |
cupric chloride results in decreased expression of AASDHPPT mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:106,077,662...106,098,695
Ensembl chr11:106,075,501...106,098,699
|
|
G |
ABCF3 |
ATP binding cassette subfamily F member 3 |
increases expression |
EXP |
cupric chloride results in increased expression of ABCF3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:184,186,199...184,194,005
Ensembl chr 3:184,186,095...184,194,012
|
|
G |
ABHD4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
EXP |
cupric chloride results in increased expression of ABHD4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr14:22,598,300...22,612,963
Ensembl chr14:22,598,290...22,612,963
|
|
G |
ACAT2 |
acetyl-CoA acetyltransferase 2 |
decreases expression |
EXP |
cupric chloride results in decreased expression of ACAT2 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
|
|
G |
ACHE |
acetylcholinesterase (Cartwright blood group) |
multiple interactions decreases activity |
ISO EXP |
cupric chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ACHE protein] cupric chloride results in decreased activity of ACHE protein Carnosine inhibits the reaction [cupric chloride results in decreased activity of ACHE protein] |
CTD |
PMID:24799335 PMID:32745495 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ACO1 |
aconitase 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of ACO1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 9:32,384,643...32,454,769
Ensembl chr 9:32,384,603...32,454,769
|
|
G |
ACSS2 |
acyl-CoA synthetase short chain family member 2 |
decreases expression |
EXP |
cupric chloride results in decreased expression of ACSS2 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962
|
|
G |
ACTB |
actin beta |
increases expression |
ISO |
cupric chloride results in increased expression of ACTB protein |
CTD |
PMID:29617964 |
|
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
|
|
G |
ADRM1 |
ADRM1 26S proteasome ubiquitin receptor |
increases expression |
EXP |
cupric chloride results in increased expression of ADRM1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr20:62,302,896...62,308,862
Ensembl chr20:62,302,093...62,308,862
|
|
G |
AHSG |
alpha 2-HS glycoprotein |
decreases expression |
EXP |
cupric chloride results in decreased expression of AHSG mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
|
|
G |
AKR1A1 |
aldo-keto reductase family 1 member A1 |
increases expression |
ISO |
cupric chloride results in increased expression of AKR1A1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 1:45,550,826...45,570,049
Ensembl chr 1:45,550,543...45,570,049
|
|
G |
ALB |
albumin |
multiple interactions |
EXP |
ALB protein inhibits the reaction [cupric chloride results in decreased activity of PROC protein] |
CTD |
PMID:11820775 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALDH1L1 |
aldehyde dehydrogenase 1 family member L1 |
increases expression |
ISO |
cupric chloride results in increased expression of ALDH1L1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:126,103,570...126,197,945
Ensembl chr 3:126,103,562...126,197,994
|
|
G |
ALDOA |
aldolase, fructose-bisphosphate A |
increases expression |
ISO |
cupric chloride results in increased expression of ALDOA protein |
CTD |
PMID:29617964 |
|
NCBI chr16:30,053,151...30,070,414
Ensembl chr16:30,053,090...30,070,420 Ensembl chr16:30,053,090...30,070,420 Ensembl chr16:30,053,090...30,070,420
|
|
G |
ALDOA |
aldolase, fructose-bisphosphate A |
increases expression |
EXP |
cupric chloride results in increased expression of ALDOA mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
|
|
G |
ALDOC |
aldolase, fructose-bisphosphate C |
decreases expression |
ISO |
cupric chloride results in decreased expression of ALDOC protein |
CTD |
PMID:29617964 |
|
NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
|
|
G |
ALKBH2 |
alkB homolog 2, alpha-ketoglutarate dependent dioxygenase |
decreases activity |
EXP |
cupric chloride results in decreased activity of ALKBH2 protein |
CTD |
PMID:28926697 |
|
NCBI chr12:109,088,189...109,093,472
Ensembl chr12:109,088,188...109,093,631
|
|
G |
ALKBH3 |
alkB homolog 3, alpha-ketoglutarate dependent dioxygenase |
decreases activity |
EXP |
cupric chloride results in decreased activity of ALKBH3 protein |
CTD |
PMID:28926697 |
|
NCBI chr11:43,880,831...43,920,274
Ensembl chr11:43,880,811...43,920,274
|
|
G |
ANKRD1 |
ankyrin repeat domain 1 |
increases expression |
EXP |
cupric chloride results in increased expression of ANKRD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:90,912,096...90,921,087
Ensembl chr10:90,912,096...90,921,087
|
|
G |
ANPEP |
alanyl aminopeptidase, membrane |
decreases expression |
EXP |
cupric chloride results in decreased expression of ANPEP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401
|
|
G |
APOM |
apolipoprotein M |
increases expression |
ISO |
cupric chloride results in increased expression of APOM mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:31,652,404...31,658,210
Ensembl chr 6:31,652,416...31,658,210
|
|
G |
APP |
amyloid beta precursor protein |
increases expression multiple interactions |
ISO |
cupric chloride results in increased expression of APP mRNA; cupric chloride results in increased expression of APP protein cupric chloride results in decreased uptake of and results in decreased degradation of APP protein modified form; PP242 inhibits the reaction [cupric chloride results in decreased uptake of and results in decreased degradation of APP protein modified form] |
CTD |
PMID:22542740 PMID:32512069 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
AR |
androgen receptor |
multiple interactions |
EXP |
[Disulfiram co-treated with cupric chloride] results in decreased expression of AR protein |
CTD |
PMID:19789329 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ATF2 |
activating transcription factor 2 |
multiple interactions |
ISO |
[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of ATF2 protein; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:30768131 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
ATF4 |
activating transcription factor 4 |
multiple interactions |
ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of ATF4 mRNA; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of ATF4 mRNA] |
CTD |
PMID:20920558 |
|
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
|
|
G |
ATM |
ATM serine/threonine kinase |
multiple interactions |
EXP |
cupric chloride results in increased phosphorylation of and results in increased activity of ATM protein |
CTD |
PMID:16959548 |
|
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,223,044...108,369,102
|
|
G |
ATOX1 |
antioxidant 1 copper chaperone |
multiple interactions |
EXP |
[cupric chloride results in increased abundance of Copper] which results in increased expression of ATOX1 mRNA; ATOX1 protein results in decreased susceptibility to [cupric chloride results in increased abundance of Copper] |
CTD |
PMID:32278528 |
|
NCBI chr 5:151,742,822...151,758,631
Ensembl chr 5:151,742,316...151,772,532
|
|
G |
ATP7A |
ATPase copper transporting alpha |
increases transport multiple interactions affects localization decreases glutathionylation increases expression |
EXP ISO |
ATP7A protein results in increased transport of cupric chloride ATP7A protein results in decreased susceptibility to [cupric chloride results in increased abundance of Copper]; ATP7A protein results in decreased uptake of [cupric chloride results in increased abundance of Copper]; cupric chloride inhibits the reaction [bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]]; cupric chloride promotes the reaction [CLU protein binds to ATP7A protein] Omeprazole inhibits the reaction [cupric chloride affects the localization of ATP7A protein] cupric chloride results in decreased glutathionylation of ATP7A protein cupric chloride inhibits the reaction [Cycloheximide results in decreased expression of ATP7A protein]; cupric chloride promotes the reaction [Deferoxamine results in increased expression of ATP7A mRNA]; Deferoxamine promotes the reaction [cupric chloride results in increased expression of ATP7A protein] |
CTD |
PMID:11092760 PMID:16317117 PMID:17009961 PMID:20566629 PMID:21242307 PMID:23174565 PMID:25337692 PMID:32278528 More...
|
|
NCBI chr X:77,910,693...78,050,395
Ensembl chr X:77,910,690...78,050,395
|
|
G |
ATP7B |
ATPase copper transporting beta |
decreases response to substance affects localization multiple interactions |
EXP ISO |
ATP7B protein results in decreased susceptibility to cupric chloride cupric chloride affects the localization of ATP7B protein ATP7B protein results in decreased susceptibility to [cupric chloride results in increased abundance of Copper]; ATP7B protein results in increased uptake of [cupric chloride results in increased abundance of Copper]; cupric chloride promotes the reaction [CLU protein binds to ATP7B protein] |
CTD |
PMID:10728692 PMID:16799059 PMID:21242307 PMID:24343273 PMID:32278528 |
|
NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,125
|
|
G |
BACE1 |
beta-secretase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of BACE1 mRNA; cupric chloride results in increased expression of BACE1 protein |
CTD |
PMID:22542740 |
|
NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
|
|
G |
BAG3 |
BAG cochaperone 3 |
increases expression |
EXP |
cupric chloride results in increased expression of BAG3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
cupric chloride results in increased expression of BAX protein [cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein; [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased expression of BAX protein; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; Ethanol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; Mannitol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; neocuproine inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; Thiourea inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein] |
CTD |
PMID:21035945 PMID:22239859 PMID:23313662 PMID:24170445 PMID:29803612 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression |
ISO EXP |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA; [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 protein; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 protein] [Disulfiram co-treated with cupric chloride] results in decreased expression of BCL2 protein cupric chloride results in decreased expression of BCL2 protein |
CTD |
PMID:20920558 PMID:21911303 PMID:23313662 PMID:24170445 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of BCL2L1 protein |
CTD |
PMID:23313662 PMID:24170445 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BID |
BH3 interacting domain death agonist |
increases expression |
EXP |
cupric chloride results in increased expression of BID mRNA |
CTD |
PMID:17211630 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
BLVRB |
biliverdin reductase B |
increases expression |
EXP |
cupric chloride results in increased expression of BLVRB mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764
|
|
G |
C1QTNF4 |
C1q and TNF related 4 |
increases expression |
ISO |
cupric chloride results in increased expression of C1QTNF4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:47,589,667...47,595,304
Ensembl chr11:47,589,667...47,594,411
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases expression increases activity decreases activity |
ISO EXP |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP3 protein; [Disulfiram binds to cupric chloride] which results in increased activity of CASP3 protein; bathocuproine sulfonate inhibits the reaction [[Disulfiram binds to cupric chloride] which results in increased activity of CASP3 protein]; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP3 protein] [cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein; [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased activity of CASP3 protein; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; Ethanol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; Mannitol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; neocuproine inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; Thiourea inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein] cupric chloride results in increased expression of CASP3 protein cupric chloride results in increased activity of CASP3 protein cupric chloride results in decreased activity of CASP3 protein |
CTD |
PMID:11239917 PMID:18056745 PMID:20920558 PMID:21035945 PMID:22954531 PMID:23313662 PMID:24170445 PMID:29803612 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP7 |
caspase 7 |
multiple interactions |
ISO EXP |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP7 protein; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP7 protein]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP7 protein] [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased activity of CASP7 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[prolinedithiocarbamate analog co-treated with cupric chloride] results in increased activity of CASP7 protein] |
CTD |
PMID:20920558 PMID:21035945 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
increases expression |
ISO |
cupric chloride results in increased expression of CASP8 protein |
CTD |
PMID:23313662 |
|
NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases expression |
ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP9 protein]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein] cupric chloride results in increased expression of CASP9 protein |
CTD |
PMID:20920558 PMID:23313662 PMID:24170445 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions decreases activity |
EXP |
Carnosine inhibits the reaction [cupric chloride results in decreased activity of CAT protein]; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased activity of CASP3 protein]; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of BAX protein]; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein] |
CTD |
PMID:29803612 PMID:32745495 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCN1 |
cellular communication network factor 1 |
increases expression |
EXP |
cupric chloride results in increased expression of CCN1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
|
|
G |
CCS |
copper chaperone for superoxide dismutase |
multiple interactions |
EXP |
cupric chloride results in increased degradation of and results in decreased expression of CCS protein |
CTD |
PMID:16531609 |
|
NCBI chr11:66,593,185...66,606,019
Ensembl chr11:66,593,153...66,606,019
|
|
G |
CD63 |
CD63 molecule |
decreases expression |
EXP |
cupric chloride results in decreased expression of CD63 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:55,725,323...55,729,673
Ensembl chr12:55,725,323...55,729,707
|
|
G |
CDC34 |
cell division cycle 34, ubiqiutin conjugating enzyme |
affects expression |
EXP |
cupric chloride affects the expression of CDC34 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:531,760...542,087
Ensembl chr19:531,760...542,092
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
affects expression |
EXP |
cupric chloride affects the expression of CDKN1A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
affects expression |
ISO |
cupric chloride affects the expression of CDKN1B protein |
CTD |
PMID:23313662 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CHORDC1 |
cysteine and histidine rich domain containing 1 |
increases expression |
EXP |
cupric chloride results in increased expression of CHORDC1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:90,200,429...90,223,049
Ensembl chr11:90,200,429...90,223,077
|
|
G |
CKMT2 |
creatine kinase, mitochondrial 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of CKMT2 protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:81,233,322...81,266,398
Ensembl chr 5:81,233,320...81,266,398
|
|
G |
CKS2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
EXP |
cupric chloride results in increased expression of CKS2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
|
|
G |
CLCN6 |
chloride voltage-gated channel 6 |
increases expression decreases expression |
EXP |
cupric chloride results in increased expression of CLCN6 mRNA cupric chloride results in decreased expression of CLCN6 mRNA |
CTD |
PMID:17211630 PMID:34921933 |
|
NCBI chr 1:11,806,191...11,843,130
Ensembl chr 1:11,806,096...11,848,079
|
|
G |
CLCN7 |
chloride voltage-gated channel 7 |
affects expression |
EXP |
cupric chloride affects the expression of CLCN7 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:1,444,935...1,475,028
Ensembl chr16:1,444,934...1,475,077
|
|
G |
CLDND1 |
claudin domain containing 1 |
increases expression |
EXP |
cupric chloride results in increased expression of CLDND1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:98,515,483...98,522,902
Ensembl chr 3:98,497,912...98,523,066
|
|
G |
CLU |
clusterin |
multiple interactions increases expression |
EXP ISO |
cupric chloride promotes the reaction [CLU protein binds to ATP7A protein]; cupric chloride promotes the reaction [CLU protein binds to ATP7B protein] cupric chloride results in increased expression of CLU mRNA |
CTD |
PMID:17211630 PMID:21242307 |
|
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
|
|
G |
COMMD1 |
copper metabolism domain containing 1 |
decreases response to substance multiple interactions decreases expression |
EXP ISO |
COMMD1 protein results in decreased susceptibility to cupric chloride cupric chloride promotes the reaction [COMMD1 protein binds to SOD1 protein] [COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK2 protein; [COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK3 protein cupric chloride results in decreased expression of COMMD1 mRNA; cupric chloride results in decreased expression of COMMD1 protein |
CTD |
PMID:17211630 PMID:24691167 PMID:25007851 |
|
NCBI chr 2:61,888,391...62,136,058
Ensembl chr 2:61,888,724...62,147,247
|
|
G |
COMMD10 |
COMM domain containing 10 |
decreases expression |
EXP |
cupric chloride results in decreased expression of COMMD10 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:116,085,025...116,293,287
Ensembl chr 5:116,085,016...116,412,762
|
|
G |
COMMD2 |
COMM domain containing 2 |
decreases expression |
EXP |
cupric chloride results in decreased expression of COMMD2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:149,738,472...149,752,489
Ensembl chr 3:149,738,472...149,752,495
|
|
G |
COMMD3 |
COMM domain containing 3 |
decreases expression |
EXP |
cupric chloride results in decreased expression of COMMD3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:22,316,388...22,320,306
Ensembl chr10:22,316,386...22,320,306
|
|
G |
COMMD4 |
COMM domain containing 4 |
decreases expression |
EXP |
cupric chloride results in decreased expression of COMMD4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr15:75,336,063...75,343,227
Ensembl chr15:75,336,020...75,343,224
|
|
G |
COMMD5 |
COMM domain containing 5 |
decreases expression |
EXP |
cupric chloride results in decreased expression of COMMD5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:144,837,978...144,853,556
Ensembl chr 8:144,841,042...144,853,736
|
|
G |
COMMD6 |
COMM domain containing 6 |
decreases expression |
EXP |
cupric chloride results in decreased expression of COMMD6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr13:75,525,214...75,549,439
Ensembl chr13:75,525,214...75,549,439
|
|
G |
COMMD7 |
COMM domain containing 7 |
decreases expression |
EXP |
cupric chloride results in decreased expression of COMMD7 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr20:32,702,699...32,743,467
Ensembl chr20:32,702,699...32,743,467
|
|
G |
COMMD8 |
COMM domain containing 8 |
decreases expression |
EXP |
cupric chloride results in decreased expression of COMMD8 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:47,450,787...47,463,702
Ensembl chr 4:47,450,787...47,463,702
|
|
G |
COX16 |
cytochrome c oxidase assembly factor COX16 |
affects expression |
EXP |
cupric chloride affects the expression of COX16 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr14:70,325,081...70,359,683
Ensembl chr14:70,325,081...70,416,984
|
|
G |
COX5B |
cytochrome c oxidase subunit 5B |
decreases expression |
ISO |
cupric chloride results in decreased expression of COX5B protein |
CTD |
PMID:29617964 |
|
NCBI chr 2:97,646,062...97,648,383
Ensembl chr 2:97,646,062...97,648,383
|
|
G |
COX6A1 |
cytochrome c oxidase subunit 6A1 |
increases expression |
ISO |
cupric chloride results in increased expression of COX6A1 protein |
CTD |
PMID:29617964 |
|
NCBI chr12:120,438,113...120,440,730
Ensembl chr12:120,438,090...120,440,737
|
|
G |
CP |
ceruloplasmin |
increases expression |
EXP |
cupric chloride results in increased expression of CP mRNA |
CTD |
PMID:15741220 |
|
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
|
|
G |
CPLX2 |
complexin 2 |
decreases expression |
ISO |
cupric chloride results in decreased expression of CPLX2 protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:175,796,533...175,884,021
Ensembl chr 5:175,796,310...175,884,021
|
|
G |
CRYAB |
crystallin alpha B |
increases expression |
EXP |
cupric chloride results in increased expression of CRYAB mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
|
|
G |
CSNK1G1 |
casein kinase 1 gamma 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of CSNK1G1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr15:64,165,525...64,356,173
Ensembl chr15:64,165,525...64,356,173
|
|
G |
CSTB |
cystatin B |
affects binding |
EXP |
CSTB protein binds to cupric chloride |
CTD |
PMID:16939620 |
|
NCBI chr21:43,773,950...43,776,308
Ensembl chr21:43,772,511...43,776,330
|
|
G |
CTSB |
cathepsin B |
multiple interactions decreases expression |
ISO |
PP242 inhibits the reaction [cupric chloride results in decreased expression of CTSB mRNA]; PP242 inhibits the reaction [cupric chloride results in decreased expression of CTSB protein] cupric chloride results in decreased expression of CTSB mRNA; cupric chloride results in decreased expression of CTSB protein |
CTD |
PMID:32512069 |
|
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
|
|
G |
CTSD |
cathepsin D |
decreases expression multiple interactions |
ISO |
cupric chloride results in decreased expression of CTSD mRNA PP242 inhibits the reaction [cupric chloride results in decreased expression of CTSD mRNA] |
CTD |
PMID:32512069 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases secretion increases expression |
EXP |
cupric chloride results in increased secretion of CXCL8 protein cupric chloride results in increased expression of CXCL8 mRNA; cupric chloride results in increased expression of CXCL8 protein |
CTD |
PMID:12865660 PMID:17211630 PMID:29355601 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYBC1 |
cytochrome b-245 chaperone 1 |
increases expression |
EXP |
cupric chloride results in increased expression of CYBC1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr17:82,442,586...82,450,752
Ensembl chr17:82,440,912...82,450,829
|
|
G |
CYCS |
cytochrome c, somatic |
multiple interactions |
ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which affects the localization of CYCS protein |
CTD |
PMID:20920558 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
decreases expression |
EXP |
cupric chloride results in decreased expression of CYFIP2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:157,266,123...157,395,594
Ensembl chr 5:157,266,079...157,395,595
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases stability multiple interactions |
ISO |
cupric chloride results in increased stability of CYP1A1 mRNA; cupric chloride results in increased stability of CYP1A1 protein [1,10-phenanthroline co-treated with cupric chloride] inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [1,10-phenanthroline co-treated with cupric chloride] inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein] |
CTD |
PMID:19896525 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP27A1 |
cytochrome P450 family 27 subfamily A member 1 |
increases expression |
ISO |
cupric chloride results in increased expression of CYP27A1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
multiple interactions |
EXP |
[CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; [CYP2B6 protein co-treated with cupric chloride co-treated with NADP] results in increased metabolism of N'-nitrosonornicotine |
CTD |
PMID:32672941 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
increases expression |
ISO |
cupric chloride results in increased expression of CYP2C38 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
|
|
G |
CYP51A1 |
cytochrome P450 family 51 subfamily A member 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of CYP51A1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions increases expression |
ISO EXP |
pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of DDIT3 mRNA] cupric chloride results in increased expression of DDIT3 mRNA |
CTD |
PMID:17211630 PMID:20920558 |
|
NCBI chr12:57,516,588...57,521,698
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DERL3 |
derlin 3 |
decreases expression |
EXP |
cupric chloride results in decreased expression of DERL3 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr22:23,834,503...23,839,006
Ensembl chr22:23,834,503...23,839,128
|
|
G |
DHCR7 |
7-dehydrocholesterol reductase |
decreases expression |
EXP |
cupric chloride results in decreased expression of DHCR7 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
|
|
G |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
increases expression |
EXP |
cupric chloride results in increased expression of DKK1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
|
|
G |
DMD |
dystrophin |
increases expression |
EXP |
cupric chloride results in increased expression of DMD mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:31,119,222...33,339,388
Ensembl chr X:31,097,677...33,339,609
|
|
G |
DNAJB1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
EXP |
cupric chloride results in increased expression of DNAJB1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,514,769...14,560,391
|
|
G |
DPYSL2 |
dihydropyrimidinase like 2 |
increases expression |
ISO |
cupric chloride results in increased expression of DPYSL2 protein |
CTD |
PMID:29617964 |
|
NCBI chr 8:26,514,031...26,658,175
Ensembl chr 8:26,514,031...26,658,178
|
|
G |
DPYSL5 |
dihydropyrimidinase like 5 |
increases expression |
ISO |
cupric chloride results in increased expression of DPYSL5 protein |
CTD |
PMID:29617964 |
|
NCBI chr 2:26,847,995...26,950,351
Ensembl chr 2:26,847,747...26,950,351
|
|
G |
DUSP1 |
dual specificity phosphatase 1 |
increases expression |
EXP |
cupric chloride results in increased expression of DUSP1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
|
|
G |
EBP |
EBP cholestenol delta-isomerase |
decreases expression |
EXP |
cupric chloride results in decreased expression of EBP mRNA |
CTD |
PMID:34921933 |
|
NCBI chr X:48,521,808...48,528,716
Ensembl chr X:48,521,799...48,528,716
|
|
G |
EGR1 |
early growth response 1 |
affects expression |
EXP |
cupric chloride affects the expression of EGR1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
ELAC2 |
elaC ribonuclease Z 2 |
affects expression |
EXP |
cupric chloride affects the expression of ELAC2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:12,991,612...13,018,027
Ensembl chr17:12,991,612...13,018,065
|
|
G |
ELOVL1 |
ELOVL fatty acid elongase 1 |
increases expression |
EXP |
cupric chloride results in increased expression of ELOVL1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:43,363,401...43,368,011
Ensembl chr 1:43,363,398...43,368,074
|
|
G |
ELOVL6 |
ELOVL fatty acid elongase 6 |
decreases expression |
EXP |
cupric chloride results in decreased expression of ELOVL6 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199
|
|
G |
EML4 |
EMAP like 4 |
decreases expression |
EXP |
cupric chloride results in decreased expression of EML4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:42,169,353...42,332,548
Ensembl chr 2:42,169,353...42,332,548
|
|
G |
ENAM |
enamelin |
affects expression |
EXP |
cupric chloride affects the expression of ENAM mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:70,628,744...70,646,824
Ensembl chr 4:70,628,744...70,646,824
|
|
G |
ENDOG |
endonuclease G |
increases expression |
ISO |
cupric chloride results in increased expression of ENDOG protein |
CTD |
PMID:22239859 |
|
NCBI chr 9:128,818,500...128,822,676
Ensembl chr 9:128,818,500...128,822,676
|
|
G |
ERG28 |
ergosterol biosynthesis 28 homolog |
decreases expression |
EXP |
cupric chloride results in decreased expression of ERG28 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr14:75,649,791...75,660,876
Ensembl chr14:75,649,791...75,660,876
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions increases activity affects response to substance decreases expression |
EXP |
cupric chloride inhibits the reaction [Estradiol binds to ESR1 protein]; cupric chloride promotes the reaction [Estradiol results in decreased expression of ESR1 mRNA]; cupric chloride promotes the reaction [Estradiol results in decreased expression of ESR1 protein]; Estradiol promotes the reaction [cupric chloride results in decreased expression of ESR1 mRNA]; Estradiol promotes the reaction [cupric chloride results in decreased expression of ESR1 protein] cupric chloride results in increased activity of ESR1 protein ESR1 protein affects the susceptibility to cupric chloride cupric chloride results in decreased expression of ESR1 mRNA; cupric chloride results in decreased expression of ESR1 protein |
CTD |
PMID:12746304 PMID:17716812 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
F2 |
coagulation factor II, thrombin |
increases expression |
ISO |
cupric chloride results in increased expression of F2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
|
|
G |
FAM219A |
family with sequence similarity 219 member A |
increases expression |
EXP |
cupric chloride results in increased expression of FAM219A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 9:34,398,184...34,458,570
Ensembl chr 9:34,398,184...34,458,570
|
|
G |
FAM89B |
family with sequence similarity 89 member B |
increases expression |
EXP |
cupric chloride results in increased expression of FAM89B mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:65,572,538...65,574,190
Ensembl chr11:65,572,349...65,574,198
|
|
G |
FASN |
fatty acid synthase |
decreases expression |
EXP |
cupric chloride results in decreased expression of FASN mRNA |
CTD |
PMID:34921933 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FDFT1 |
farnesyl-diphosphate farnesyltransferase 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of FDFT1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,304
|
|
G |
FETUB |
fetuin B |
increases expression |
ISO |
cupric chloride results in increased expression of FETUB mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:186,635,969...186,653,141
Ensembl chr 3:186,635,969...186,653,141
|
|
G |
FGF1 |
fibroblast growth factor 1 |
multiple interactions |
EXP |
[amlexanox binds to FGF1 protein] inhibits the reaction [cupric chloride results in increased oxidation of FGF1 protein] |
CTD |
PMID:16300395 |
|
NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
|
|
G |
FGFR1 |
fibroblast growth factor receptor 1 |
affects expression |
EXP |
cupric chloride affects the expression of FGFR1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
|
|
G |
FHL3 |
four and a half LIM domains 3 |
increases expression |
EXP |
cupric chloride results in increased expression of FHL3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:37,996,770...38,005,514
Ensembl chr 1:37,996,770...38,005,606
|
|
G |
FKBP4 |
FKBP prolyl isomerase 4 |
increases expression |
EXP |
cupric chloride results in increased expression of FKBP4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:2,794,970...2,805,423
Ensembl chr12:2,794,970...2,805,423
|
|
G |
FMO5 |
flavin containing dimethylaniline monoxygenase 5 |
decreases expression |
EXP |
cupric chloride results in decreased expression of FMO5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:147,184,305...147,227,284
Ensembl chr 1:147,175,351...147,243,050
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
cupric chloride results in increased expression of FOS mRNA |
CTD |
PMID:17211630 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FTH1P5 |
ferritin heavy chain 1 pseudogene 5 |
increases expression |
EXP |
cupric chloride results in increased expression of FTH1P5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:50,912,550...50,913,462
Ensembl chr 6:50,912,712...50,913,256
|
|
G |
FUBP1 |
far upstream element binding protein 1 |
increases expression |
ISO |
cupric chloride results in increased expression of FUBP1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 1:77,944,055...77,979,501
Ensembl chr 1:77,944,055...77,979,110
|
|
G |
FXYD2 |
FXYD domain containing ion transport regulator 2 |
affects expression |
EXP |
cupric chloride affects the expression of FXYD2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:117,820,057...117,828,089
Ensembl chr11:117,800,844...117,828,698
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
multiple interactions decreases activity |
EXP |
Carnosine inhibits the reaction [cupric chloride results in decreased activity of G6PD protein] |
CTD |
PMID:32745495 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GABARAPL3 |
GABA type A receptor associated protein like 3 pseudogene |
increases expression |
EXP |
cupric chloride results in increased expression of GABARAPL3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr15:90,346,527...90,349,447
Ensembl chr15:90,348,844...90,349,197
|
|
G |
GABRE |
gamma-aminobutyric acid type A receptor subunit epsilon |
increases expression |
EXP |
cupric chloride results in increased expression of GABRE mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:151,953,124...151,974,676
Ensembl chr X:151,953,124...151,974,680
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
increases expression |
EXP |
cupric chloride results in increased expression of GADD45A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
increases expression |
EXP |
cupric chloride results in increased expression of GCLC mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
increases expression |
EXP |
cupric chloride results in increased expression of GCLM mRNA |
CTD |
PMID:17211630 PMID:24343273 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GDI1 |
GDP dissociation inhibitor 1 |
increases expression |
ISO |
cupric chloride results in increased expression of GDI1 protein |
CTD |
PMID:29617964 |
|
NCBI chr X:154,437,154...154,443,467
Ensembl chr X:154,436,913...154,443,467
|
|
G |
GLA |
galactosidase alpha |
increases expression |
EXP |
cupric chloride results in increased expression of GLA mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:101,397,803...101,407,925
Ensembl chr X:101,393,273...101,408,012
|
|
G |
GLUD1 |
glutamate dehydrogenase 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of GLUD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843
|
|
G |
GPRC5C |
G protein-coupled receptor class C group 5 member C |
decreases expression |
EXP |
cupric chloride results in decreased expression of GPRC5C mRNA |
CTD |
PMID:34921933 |
|
NCBI chr17:74,432,088...74,451,658
Ensembl chr17:74,424,851...74,451,653
|
|
G |
GSR |
glutathione-disulfide reductase |
decreases activity multiple interactions |
EXP |
cupric chloride results in decreased activity of GSR protein Carnosine inhibits the reaction [cupric chloride results in decreased activity of GSR protein] |
CTD |
PMID:32745495 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GTPBP2 |
GTP binding protein 2 |
affects expression |
EXP |
cupric chloride affects the expression of GTPBP2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:43,620,494...43,631,333
Ensembl chr 6:43,605,316...43,629,264
|
|
G |
GTPBP6 |
GTP binding protein 6 (putative) |
increases expression |
EXP |
cupric chloride results in increased expression of GTPBP6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:304,759...318,796 NCBI chr Y:304,759...318,796
Ensembl chr X:304,529...318,796
|
|
G |
GYPE |
glycophorin E (MNS blood group) |
affects expression |
EXP |
cupric chloride affects the expression of GYPE mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:143,870,864...143,905,559
Ensembl chr 4:143,870,864...143,905,563
|
|
G |
H2BC21 |
H2B clustered histone 21 |
decreases expression |
EXP |
cupric chloride results in decreased expression of H2BC21 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 1:149,884,459...149,886,682
Ensembl chr 1:149,884,459...149,886,682
|
|
G |
HAMP |
hepcidin antimicrobial peptide |
increases expression |
ISO |
cupric chloride results in increased expression of HAMP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
|
|
G |
HEXA |
hexosaminidase subunit alpha |
decreases expression multiple interactions |
ISO |
cupric chloride results in decreased expression of HEXA mRNA PP242 inhibits the reaction [cupric chloride results in decreased expression of HEXA mRNA] |
CTD |
PMID:32512069 |
|
NCBI chr15:72,340,924...72,376,014
Ensembl chr15:72,340,924...72,376,420
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases stability affects localization decreases hydroxylation |
EXP |
Ascorbic Acid inhibits the reaction [cupric chloride results in decreased hydroxylation of HIF1A protein]; Ascorbic Acid inhibits the reaction [cupric chloride results in increased stability of HIF1A protein]; cupric chloride results in decreased hydroxylation of and results in decreased degradation of HIF1A protein cupric chloride affects the localization of HIF1A protein |
CTD |
PMID:15741220 PMID:19074761 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HK1 |
hexokinase 1 |
decreases activity |
ISO |
cupric chloride results in decreased activity of HK1 protein |
CTD |
PMID:22349057 |
|
NCBI chr10:69,270,000...69,401,882
Ensembl chr10:69,269,984...69,401,884
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
EXP |
cupric chloride results in decreased expression of HMGCR mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
|
|
G |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
EXP |
cupric chloride results in increased expression of HMOX1 mRNA; cupric chloride results in increased expression of HMOX1 protein |
CTD |
PMID:17211630 PMID:21242307 PMID:24343273 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HSD17B7 |
hydroxysteroid 17-beta dehydrogenase 7 |
decreases expression |
EXP |
cupric chloride results in decreased expression of HSD17B7 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 1:162,790,702...162,812,823
Ensembl chr 1:162,790,702...162,812,823
|
|
G |
HSP90AA1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
EXP |
cupric chloride results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
multiple interactions |
ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSP90B1 mRNA; [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSP90B1 protein; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSP90B1 mRNA] |
CTD |
PMID:20920558 |
|
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
|
|
G |
HSPA1A |
heat shock protein family A (Hsp70) member 1A |
affects expression |
EXP |
cupric chloride affects the expression of HSPA1A mRNA |
CTD |
PMID:20945374 |
|
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
|
|
G |
HSPA1B |
heat shock protein family A (Hsp70) member 1B |
increases expression |
EXP |
cupric chloride results in increased expression of HSPA1B mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 mRNA; [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 protein; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased expression of HSPA5 mRNA] |
CTD |
PMID:20920558 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPA6 |
heat shock protein family A (Hsp70) member 6 |
increases expression |
EXP |
cupric chloride results in increased expression of HSPA6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
|
|
G |
HSPA9 |
heat shock protein family A (Hsp70) member 9 |
decreases expression |
ISO |
cupric chloride results in decreased expression of HSPA9 protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:138,553,756...138,575,401
Ensembl chr 5:138,553,756...138,575,675
|
|
G |
HSPB1 |
heat shock protein family B (small) member 1 |
increases expression |
EXP |
cupric chloride results in increased expression of HSPB1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
|
|
G |
ID2 |
inhibitor of DNA binding 2 |
affects expression |
EXP |
cupric chloride affects the expression of ID2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
|
|
G |
IDH3A |
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha |
decreases expression |
ISO |
cupric chloride results in decreased expression of IDH3A protein |
CTD |
PMID:29617964 |
|
NCBI chr15:78,149,362...78,171,945
Ensembl chr15:78,131,498...78,171,945
|
|
G |
IDI1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of IDI1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
|
|
G |
IER2 |
immediate early response 2 |
increases expression |
EXP |
cupric chloride results in increased expression of IER2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:13,150,411...13,154,911
Ensembl chr19:13,150,411...13,154,911
|
|
G |
IER5 |
immediate early response 5 |
increases expression |
EXP |
cupric chloride results in increased expression of IER5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:181,088,700...181,092,900
Ensembl chr 1:181,088,700...181,092,900
|
|
G |
IFIT1 |
interferon induced protein with tetratricopeptide repeats 1 |
increases expression |
EXP |
cupric chloride results in increased expression of IFIT1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
cupric chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]] |
CTD |
PMID:8975779 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IGF1 |
insulin like growth factor 1 |
increases expression |
ISO |
cupric chloride results in increased expression of IGF1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGHMBP2 |
immunoglobulin mu DNA binding protein 2 |
increases expression |
EXP |
cupric chloride results in increased expression of IGHMBP2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:68,903,891...68,940,601
Ensembl chr11:68,903,863...68,940,602
|
|
G |
IKBKG |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
increases expression |
EXP |
cupric chloride results in increased expression of IKBKG mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
|
|
G |
IL1A |
interleukin 1 alpha |
increases secretion |
EXP |
cupric chloride results in increased secretion of IL1A protein |
CTD |
PMID:22954531 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP |
cupric chloride inhibits the reaction [TNF protein results in increased secretion of IL6 protein] |
CTD |
PMID:23285694 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IMMT |
inner membrane mitochondrial protein |
decreases expression |
ISO |
cupric chloride results in decreased expression of IMMT protein |
CTD |
PMID:29617964 |
|
NCBI chr 2:86,143,936...86,195,462
Ensembl chr 2:86,143,932...86,195,472
|
|
G |
IRS2 |
insulin receptor substrate 2 |
increases expression |
EXP |
cupric chloride results in increased expression of IRS2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr13:109,752,695...109,786,583
Ensembl chr13:109,752,695...109,786,583
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP ISO |
cupric chloride results in increased expression of JUN mRNA [[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of JUN protein; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of JUN protein] [Disulfiram co-treated with cupric chloride co-treated with Doxorubicin] results in increased expression of and results in increased phosphorylation of JUN protein |
CTD |
PMID:17211630 PMID:21911303 PMID:30768131 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
KCNIP1 |
potassium voltage-gated channel interacting protein 1 |
increases expression |
EXP |
cupric chloride results in increased expression of KCNIP1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 5:170,353,487...170,736,632
Ensembl chr 5:170,353,487...170,736,632
|
|
G |
KDM2A |
lysine demethylase 2A |
increases expression |
EXP |
cupric chloride results in increased expression of KDM2A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:67,119,263...67,258,082
Ensembl chr11:67,119,263...67,258,082
|
|
G |
KDM3A |
lysine demethylase 3A |
increases expression |
EXP |
cupric chloride results in increased expression of KDM3A mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716
|
|
G |
KIF5A |
kinesin family member 5A |
decreases activity multiple interactions |
EXP |
cupric chloride results in decreased activity of KIF5A protein Cysteine inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]; Dithiothreitol inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein]; Egtazic Acid inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein] |
CTD |
PMID:24853401 |
|
NCBI chr12:57,550,044...57,586,633
Ensembl chr12:57,546,026...57,586,633
|
|
G |
KLF6 |
KLF transcription factor 6 |
affects expression |
EXP |
cupric chloride affects the expression of KLF6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
|
|
G |
KNG1 |
kininogen 1 |
increases expression |
ISO |
cupric chloride results in increased expression of KNG1 mRNA; cupric chloride results in increased expression of KNG2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
|
|
G |
LAMP1 |
lysosomal associated membrane protein 1 |
multiple interactions decreases expression |
ISO |
PP242 inhibits the reaction [cupric chloride results in decreased expression of LAMP1 mRNA]; PP242 inhibits the reaction [cupric chloride results in decreased expression of LAMP1 protein] cupric chloride results in decreased expression of LAMP1 mRNA; cupric chloride results in decreased expression of LAMP1 protein |
CTD |
PMID:32512069 |
|
NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672
|
|
G |
LAMP2 |
lysosomal associated membrane protein 2 |
multiple interactions decreases expression |
ISO |
PP242 inhibits the reaction [cupric chloride results in decreased expression of LAMP2 mRNA] |
CTD |
PMID:32512069 |
|
NCBI chr X:120,426,148...120,469,349
Ensembl chr X:120,426,148...120,469,365
|
|
G |
LCAT |
lecithin-cholesterol acyltransferase |
increases expression |
ISO |
cupric chloride results in increased expression of LCAT mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
|
|
G |
LOX |
lysyl oxidase |
increases activity multiple interactions |
ISO EXP |
cupric chloride results in increased activity of LOX protein Aminopropionitrile inhibits the reaction [cupric chloride results in increased activity of LOX protein] |
CTD |
PMID:22367676 PMID:25044713 |
|
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
|
|
G |
LY6E |
lymphocyte antigen 6 family member E |
increases expression |
ISO |
cupric chloride results in increased expression of LY6E mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:143,018,529...143,022,409
Ensembl chr 8:143,017,982...143,023,832
|
|
G |
MAD2L1BP |
MAD2L1 binding protein |
increases expression |
EXP |
cupric chloride results in increased expression of MAD2L1BP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:43,629,540...43,640,941
Ensembl chr 6:43,629,540...43,640,941
|
|
G |
MAFG |
MAF bZIP transcription factor G |
increases expression |
EXP |
cupric chloride results in increased expression of MAFG mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
|
|
G |
MAGEA2 |
MAGE family member A2 |
increases expression |
EXP |
cupric chloride results in increased expression of MAGEA2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:152,749,863...152,753,884
Ensembl chr X:152,749,863...152,753,884
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
increases expression multiple interactions |
EXP ISO |
cupric chloride results in increased expression of MAP1LC3B mRNA cupric chloride results in increased expression of MAP1LC3B protein modified form Acetylcysteine inhibits the reaction [cupric chloride results in increased expression of MAP1LC3B protein modified form]; cupric chloride inhibits the reaction [3-methyladenine results in decreased expression of MAP1LC3B protein modified form]; PP242 promotes the reaction [cupric chloride results in increased expression of MAP1LC3B protein modified form] |
CTD |
PMID:17211630 PMID:32512069 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:20920558 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:20920558 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
[Disulfiram binds to cupric chloride] which results in increased activity of MAPK8 protein; bathocuproine sulfonate inhibits the reaction [[Disulfiram binds to cupric chloride] which results in increased activity of MAPK8 protein]; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP3 protein]; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP7 protein]; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP9 protein] [[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of MAPK8 protein; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:11239917 PMID:20920558 PMID:30768131 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MCM2 |
minichromosome maintenance complex component 2 |
multiple interactions |
EXP |
cupric chloride promotes the reaction [Disulfiram results in decreased expression of MCM2 mRNA] |
CTD |
PMID:19789329 |
|
NCBI chr 3:127,598,411...127,622,436
Ensembl chr 3:127,598,410...127,622,436
|
|
G |
MCM5 |
minichromosome maintenance complex component 5 |
multiple interactions |
EXP |
cupric chloride promotes the reaction [Disulfiram results in decreased expression of MCM5 mRNA] |
CTD |
PMID:19789329 |
|
NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431
|
|
G |
MDH2 |
malate dehydrogenase 2 |
increases expression |
ISO |
cupric chloride results in increased expression of MDH2 protein |
CTD |
PMID:29617964 |
|
NCBI chr 7:76,048,106...76,067,508
Ensembl chr 7:76,048,051...76,067,508
|
|
G |
MED15 |
mediator complex subunit 15 |
increases expression |
EXP |
cupric chloride results in increased expression of MED15 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr22:20,507,610...20,587,619
Ensembl chr22:20,495,913...20,587,632
|
|
G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
multiple interactions |
EXP |
[Disulfiram co-treated with cupric chloride] affects the expression of and affects the activity of MGMT protein |
CTD |
PMID:24193513 |
|
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
|
|
G |
MLLT11 |
MLLT11 transcription factor 7 cofactor |
increases expression |
EXP |
cupric chloride results in increased expression of MLLT11 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
increases secretion |
ISO |
cupric chloride results in increased secretion of MMP2 protein |
CTD |
PMID:11045606 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MRPL4 |
mitochondrial ribosomal protein L4 |
increases expression |
EXP |
cupric chloride results in increased expression of MRPL4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:10,251,951...10,260,055
Ensembl chr19:10,251,901...10,260,055
|
|
G |
MSRB1 |
methionine sulfoxide reductase B1 |
increases expression |
EXP |
cupric chloride results in increased expression of MSRB1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:1,938,229...1,943,199
Ensembl chr16:1,938,229...1,943,199
|
|
G |
MT1A |
metallothionein 1A |
increases expression |
EXP ISO |
cupric chloride results in increased expression of MT1A mRNA |
CTD |
PMID:17211630 PMID:23174565 |
|
NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087
|
|
G |
MT1B |
metallothionein 1B |
multiple interactions increases expression |
EXP |
cupric chloride promotes the reaction [Disulfiram results in increased expression of MT1B mRNA] cupric chloride results in increased expression of MT1B mRNA |
CTD |
PMID:17211630 PMID:19789329 |
|
NCBI chr16:56,651,886...56,653,204
Ensembl chr16:56,651,886...56,653,204
|
|
G |
MT1E |
metallothionein 1E |
increases expression |
EXP |
cupric chloride results in increased expression of MT1E mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:56,625,781...56,627,112
Ensembl chr16:56,625,475...56,627,112
|
|
G |
MT1F |
metallothionein 1F |
multiple interactions increases expression decreases expression |
EXP |
cupric chloride promotes the reaction [Disulfiram results in increased expression of MT1F mRNA] cupric chloride results in increased expression of MT1F mRNA cupric chloride deficiency results in decreased expression of MT1F mRNA |
CTD |
PMID:17211630 PMID:19789329 |
|
NCBI chr16:56,657,959...56,659,303
Ensembl chr16:56,657,731...56,660,698
|
|
G |
MT1G |
metallothionein 1G |
multiple interactions increases expression |
EXP |
cupric chloride promotes the reaction [Disulfiram results in increased expression of MT1G mRNA] cupric chloride results in increased expression of MT1G mRNA |
CTD |
PMID:19789329 PMID:32870474 |
|
NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,730...56,668,065
|
|
G |
MT1L |
metallothionein 1L, pseudogene |
increases expression |
EXP |
cupric chloride results in increased expression of MT1L mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:56,617,461...56,618,818
Ensembl chr16:56,617,563...56,618,680
|
|
G |
MT1X |
metallothionein 1X |
multiple interactions increases expression decreases expression |
EXP |
cupric chloride promotes the reaction [Disulfiram results in increased expression of MT1X mRNA] cupric chloride results in increased expression of MT1X mRNA cupric chloride deficiency results in decreased expression of MT1X mRNA |
CTD |
PMID:17211630 PMID:19789329 PMID:24343273 |
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
multiple interactions increases expression affects expression |
EXP ISO |
cupric chloride promotes the reaction [Disulfiram results in increased expression of MT2A mRNA] cupric chloride results in increased expression of MT2A mRNA cupric chloride affects the expression of MT2A mRNA |
CTD |
PMID:17211630 PMID:17409708 PMID:19789329 PMID:20945374 PMID:23174565 |
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
increases phosphorylation |
ISO |
cupric chloride results in increased phosphorylation of MTOR protein |
CTD |
PMID:32512069 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
MVD |
mevalonate diphosphate decarboxylase |
decreases expression |
EXP |
cupric chloride results in decreased expression of MVD mRNA |
CTD |
PMID:34921933 |
|
NCBI chr16:88,651,940...88,663,091
Ensembl chr16:88,651,935...88,663,161
|
|
G |
NCF2 |
neutrophil cytosolic factor 2 |
increases expression |
EXP |
cupric chloride results in increased expression of NCF2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:183,555,562...183,601,849
Ensembl chr 1:183,554,461...183,590,905
|
|
G |
NDUFS1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of NDUFS1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 2:206,114,817...206,159,444
Ensembl chr 2:206,114,817...206,159,509
|
|
G |
NDUFS4 |
NADH:ubiquinone oxidoreductase subunit S4 |
decreases expression |
ISO |
cupric chloride results in decreased expression of NDUFS4 protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:53,560,639...53,683,338
Ensembl chr 5:53,560,633...53,683,338
|
|
G |
NDUFV1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of NDUFV1 protein |
CTD |
PMID:29617964 |
|
NCBI chr11:67,606,936...67,612,554
Ensembl chr11:67,605,653...67,612,554
|
|
G |
NDUFV3 |
NADH:ubiquinone oxidoreductase subunit V3 |
decreases expression |
ISO |
cupric chloride results in decreased expression of NDUFV3 protein |
CTD |
PMID:29617964 |
|
NCBI chr21:42,893,309...42,913,299
Ensembl chr21:42,879,644...42,913,304
|
|
G |
NEFL |
neurofilament light chain |
decreases expression |
ISO |
cupric chloride results in decreased expression of NEFL protein |
CTD |
PMID:29617964 |
|
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
|
|
G |
NEU1 |
neuraminidase 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of NEU1 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 6:31,857,659...31,862,821
Ensembl chr 6:31,857,659...31,862,905
|
|
G |
NFIX |
nuclear factor I X |
decreases expression |
EXP |
cupric chloride results in decreased expression of NFIX mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:12,995,475...13,098,796
Ensembl chr19:12,995,475...13,098,796
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
decreases expression |
ISO |
cupric chloride results in decreased expression of NFKBIA protein |
CTD |
PMID:24530511 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NME1 |
NME/NM23 nucleoside diphosphate kinase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of NME1 protein |
CTD |
PMID:29617964 |
|
NCBI chr17:51,153,559...51,162,168
Ensembl chr17:51,153,559...51,162,428
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
ISO |
cupric chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]] cupric chloride results in increased expression of NOS2 protein |
CTD |
PMID:8975779 PMID:23313662 PMID:24170445 PMID:24530511 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NUDT5 |
nudix hydrolase 5 |
increases expression |
EXP |
cupric chloride results in increased expression of NUDT5 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:12,165,330...12,195,891
Ensembl chr10:12,165,330...12,196,144
|
|
G |
NUP107 |
nucleoporin 107 |
increases expression |
EXP |
cupric chloride results in increased expression of NUP107 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:68,686,978...68,745,809
Ensembl chr12:68,686,951...68,745,809
|
|
G |
P2RX2 |
purinergic receptor P2X 2 |
multiple interactions |
ISO |
cupric chloride promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein] |
CTD |
PMID:16190872 |
|
NCBI chr12:132,618,776...132,622,388
Ensembl chr12:132,618,776...132,622,388
|
|
G |
P3H4 |
prolyl 3-hydroxylase family member 4 (inactive) |
affects expression |
EXP |
cupric chloride affects the expression of P3H4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:41,801,953...41,811,949
Ensembl chr17:41,801,947...41,812,604
|
|
G |
PALLD |
palladin, cytoskeletal associated protein |
increases expression |
EXP |
cupric chloride results in increased expression of PALLD mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 4:168,497,052...168,928,441
Ensembl chr 4:168,497,052...168,928,457
|
|
G |
PAQR8 |
progestin and adipoQ receptor family member 8 |
decreases expression |
EXP |
cupric chloride results in decreased expression of PAQR8 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:52,362,151...52,407,777
Ensembl chr 6:52,361,421...52,407,777
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions increases expression |
EXP ISO |
[Disulfiram co-treated with cupric chloride] results in increased cleavage of PARP1 protein; [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased cleavage of PARP1 protein cupric chloride results in increased expression of PARP1 protein |
CTD |
PMID:19789329 PMID:21035945 PMID:23313662 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCM1 |
pericentriolar material 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of PCM1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:17,922,988...18,029,948
Ensembl chr 8:17,922,842...18,029,948
|
|
G |
PCYT2 |
phosphate cytidylyltransferase 2, ethanolamine |
decreases expression |
EXP |
cupric chloride results in decreased expression of PCYT2 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr17:81,900,958...81,911,399
Ensembl chr17:81,900,958...81,911,432
|
|
G |
PDIA3 |
protein disulfide isomerase family A member 3 |
decreases expression |
ISO |
cupric chloride results in decreased expression of PDIA3 protein |
CTD |
PMID:29617964 |
|
NCBI chr15:43,746,438...43,773,278
Ensembl chr15:43,746,394...43,773,279
|
|
G |
PDZK1 |
PDZ domain containing 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of PDZK1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:145,670,852...145,707,400
Ensembl chr 1:145,670,852...145,708,148
|
|
G |
PEG10 |
paternally expressed 10 |
decreases expression |
EXP |
cupric chloride results in decreased expression of PEG10 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
|
|
G |
PFKP |
phosphofructokinase, platelet |
increases expression |
EXP |
cupric chloride results in increased expression of PFKP mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:3,067,548...3,136,805
Ensembl chr10:3,066,333...3,137,718
|
|
G |
PGAM1 |
phosphoglycerate mutase 1 |
increases expression |
ISO |
cupric chloride results in increased expression of PGAM1 protein |
CTD |
PMID:29617964 |
|
NCBI chr10:97,426,191...97,433,444
Ensembl chr10:97,426,191...97,433,444
|
|
G |
PGR |
progesterone receptor |
multiple interactions increases expression |
EXP |
cupric chloride promotes the reaction [Estradiol results in increased expression of PGR mRNA]; cupric chloride promotes the reaction [Estradiol results in increased expression of PGR protein]; Estradiol promotes the reaction [cupric chloride results in increased expression of PGR mRNA]; Estradiol promotes the reaction [cupric chloride results in increased expression of PGR protein]; fulvestrant inhibits the reaction [cupric chloride results in increased expression of PGR mRNA]; fulvestrant inhibits the reaction [cupric chloride results in increased expression of PGR protein] cupric chloride results in increased expression of PGR mRNA; cupric chloride results in increased expression of PGR protein |
CTD |
PMID:12746304 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PHYHIP |
phytanoyl-CoA 2-hydroxylase interacting protein |
decreases expression |
EXP |
cupric chloride results in decreased expression of PHYHIP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:22,219,703...22,232,099
Ensembl chr 8:22,219,703...22,232,101
|
|
G |
PITPNC1 |
phosphatidylinositol transfer protein cytoplasmic 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of PITPNC1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:67,377,281...67,697,256
Ensembl chr17:67,377,281...67,697,256
|
|
G |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression multiple interactions |
EXP |
cupric chloride results in increased expression of PMAIP1 mRNA [prolinedithiocarbamate analog co-treated with cupric chloride] results in increased expression of PMAIP1 protein |
CTD |
PMID:20713136 PMID:21035945 |
|
NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
|
|
G |
POMP |
proteasome maturation protein |
increases expression |
EXP |
cupric chloride results in increased expression of POMP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr13:28,659,130...28,678,959
Ensembl chr13:28,659,065...28,678,959
|
|
G |
PRDX1 |
peroxiredoxin 1 |
increases expression |
EXP |
cupric chloride results in increased expression of PRDX1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
|
|
G |
PRDX3 |
peroxiredoxin 3 |
decreases expression |
ISO |
cupric chloride results in decreased expression of PRDX3 protein |
CTD |
PMID:29617964 |
|
NCBI chr10:119,167,720...119,178,812
Ensembl chr10:119,167,720...119,178,812
|
|
G |
PRNP |
prion protein |
multiple interactions increases expression |
ISO |
[NADP co-treated with cupric chloride] promotes the reaction [PRNP protein binds to PRNP protein] bathocuproine sulfonate inhibits the reaction [cupric chloride results in increased expression of PRNP protein] cupric chloride results in increased expression of PRNP mRNA; cupric chloride results in increased expression of PRNP protein |
CTD |
PMID:16148034 PMID:16990274 |
|
NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
|
|
G |
PROC |
protein C, inactivator of coagulation factors Va and VIIIa |
multiple interactions |
EXP |
ALB protein inhibits the reaction [cupric chloride results in decreased activity of PROC protein]; aspartyl-alanyl-histidyl-lysine inhibits the reaction [cupric chloride results in decreased activity of PROC protein]; cupric chloride binds to and results in decreased activity of PROC protein |
CTD |
PMID:11820775 |
|
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
|
|
G |
PSMB2 |
proteasome 20S subunit beta 2 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMB2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:35,599,541...35,641,526
Ensembl chr 1:35,599,541...35,641,526
|
|
G |
PSMB3 |
proteasome 20S subunit beta 3 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMB3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:38,752,741...38,764,225
Ensembl chr17:38,752,741...38,764,225
|
|
G |
PSMB7 |
proteasome 20S subunit beta 7 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMB7 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 9:124,353,465...124,415,442
Ensembl chr 9:124,353,465...124,415,444
|
|
G |
PSMC1 |
proteasome 26S subunit, ATPase 1 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMC1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr14:90,256,553...90,275,429
Ensembl chr14:90,256,527...90,275,429
|
|
G |
PSMC4 |
proteasome 26S subunit, ATPase 4 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMC4 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr19:39,971,165...39,981,764
Ensembl chr19:39,971,165...39,981,764
|
|
G |
PSMD1 |
proteasome 26S subunit, non-ATPase 1 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:231,056,867...231,172,827
Ensembl chr 2:231,056,845...231,173,116
|
|
G |
PSMD11 |
proteasome 26S subunit, non-ATPase 11 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMD11 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:32,444,510...32,483,319
Ensembl chr17:32,444,379...32,483,319
|
|
G |
PSMD13 |
proteasome 26S subunit, non-ATPase 13 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMD13 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:236,976...252,984
Ensembl chr11:236,966...252,984
|
|
G |
PSMD14 |
proteasome 26S subunit, non-ATPase 14 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMD14 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:161,308,425...161,411,717
Ensembl chr 2:161,308,425...161,411,717
|
|
G |
PSMD2 |
proteasome 26S subunit ubiquitin receptor, non-ATPase 2 |
increases expression |
EXP |
cupric chloride results in increased expression of PSMD2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:184,299,241...184,309,050
Ensembl chr 3:184,299,198...184,309,050
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
cupric chloride results in increased expression of PTGS2 protein |
CTD |
PMID:23313662 PMID:24170445 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTPRO |
protein tyrosine phosphatase receptor type O |
decreases expression |
EXP |
cupric chloride results in decreased expression of PTPRO mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:15,322,508...15,598,331
Ensembl chr12:15,322,257...15,602,175
|
|
G |
PURA |
purine rich element binding protein A |
decreases expression |
ISO |
cupric chloride results in decreased expression of PURA protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:140,114,109...140,125,619
Ensembl chr 5:140,107,777...140,125,619
|
|
G |
QKI |
QKI, KH domain containing RNA binding |
increases expression |
EXP |
cupric chloride results in increased expression of QKI mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 6:163,414,718...163,578,592
Ensembl chr 6:163,414,000...163,578,592
|
|
G |
RALGAPA1 |
Ral GTPase activating protein catalytic subunit alpha 1 |
affects expression |
EXP |
cupric chloride affects the expression of RALGAPA1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr14:35,538,356...35,809,295
Ensembl chr14:35,538,352...35,809,304
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
cupric chloride results in increased phosphorylation of and affects the localization of RELA protein |
CTD |
PMID:24530511 |
|
NCBI chr11:65,653,601...65,662,916
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RHOB |
ras homolog family member B |
decreases expression |
EXP |
cupric chloride results in decreased expression of ARHB mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440
|
|
G |
RNF181 |
ring finger protein 181 |
affects expression |
EXP |
cupric chloride affects the expression of RNF181 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 2:85,595,745...85,597,708
Ensembl chr 2:85,595,725...85,597,708
|
|
G |
RPL32 |
ribosomal protein L32 |
affects expression |
EXP |
cupric chloride affects the expression of RPL32 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:12,834,485...12,841,582
Ensembl chr 3:12,834,485...12,841,582
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
increases phosphorylation |
ISO |
cupric chloride results in increased phosphorylation of RPS6KB1 protein |
CTD |
PMID:32512069 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
RRAD |
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
increases expression |
EXP |
cupric chloride results in increased expression of RRAD mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:66,921,685...66,925,535
Ensembl chr16:66,921,679...66,925,536
|
|
G |
RYBP |
RING1 and YY1 binding protein |
affects expression |
EXP |
cupric chloride affects the expression of RYBP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:72,374,593...72,446,623
Ensembl chr 3:72,371,825...72,446,621
|
|
G |
SBDS |
SBDS ribosome maturation factor |
increases expression |
EXP |
cupric chloride results in increased expression of SBDS mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:66,987,680...66,995,586
Ensembl chr 7:66,987,680...66,995,693
|
|
G |
SCD |
stearoyl-CoA desaturase |
decreases expression |
EXP |
cupric chloride results in decreased expression of SCD mRNA |
CTD |
PMID:34921933 |
|
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
|
|
G |
SCO2 |
synthesis of cytochrome C oxidase 2 |
multiple interactions |
EXP |
cupric chloride promotes the reaction [Bezafibrate results in increased activity of SCO2 protein mutant form] |
CTD |
PMID:22515166 |
|
NCBI chr22:50,523,568...50,526,442
Ensembl chr22:50,523,568...50,526,461
|
|
G |
SDF2 |
stromal cell derived factor 2 |
increases expression |
EXP |
cupric chloride results in increased expression of SDF2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:28,648,346...28,662,194
Ensembl chr17:28,648,346...28,662,189
|
|
G |
SELENOK |
selenoprotein K |
increases expression |
EXP |
cupric chloride results in increased expression of SELENOK mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:53,884,417...53,891,859
Ensembl chr 3:53,884,417...53,891,885
|
|
G |
SELENOP |
selenoprotein P |
decreases expression |
EXP |
cupric chloride results in decreased expression of SELENOP mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
|
|
G |
SEPTIN4 |
septin 4 |
decreases expression |
ISO |
cupric chloride results in decreased expression of SEPTIN4 protein |
CTD |
PMID:29617964 |
|
NCBI chr17:58,520,256...58,544,328
Ensembl chr17:58,520,250...58,544,368
|
|
G |
SEPTIN8 |
septin 8 |
decreases expression |
ISO |
cupric chloride results in decreased expression of SEPTIN8 protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:132,750,819...132,780,083
Ensembl chr 5:132,750,819...132,807,241
|
|
G |
SERPINF1 |
serpin family F member 1 |
increases expression |
ISO |
cupric chloride results in increased expression of SERPINF1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:1,762,060...1,777,565
Ensembl chr17:1,762,029...1,777,565
|
|
G |
SHANK2 |
SH3 and multiple ankyrin repeat domains 2 |
multiple interactions |
ISO |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK2 protein |
CTD |
PMID:25007851 |
|
NCBI chr11:70,467,854...71,253,228
Ensembl chr11:70,467,854...71,252,577
|
|
G |
SHANK3 |
SH3 and multiple ankyrin repeat domains 3 |
multiple interactions |
ISO |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK3 protein |
CTD |
PMID:25007851 |
|
NCBI chr22:50,672,823...50,733,212
Ensembl chr22:50,674,415...50,733,212
|
|
G |
SIRT7 |
sirtuin 7 |
increases expression |
EXP |
cupric chloride results in increased expression of SIRT7 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr17:81,911,939...81,918,176
Ensembl chr17:81,911,939...81,921,323
|
|
G |
SLC11A2 |
solute carrier family 11 member 2 |
multiple interactions |
EXP |
cupric chloride inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] |
CTD |
PMID:12220667 |
|
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
|
|
G |
SLC13A3 |
solute carrier family 13 member 3 |
decreases expression |
EXP |
cupric chloride results in decreased expression of SLC13A3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr20:46,557,828...46,684,485
Ensembl chr20:46,557,823...46,684,467
|
|
G |
SLC22A18 |
solute carrier family 22 member 18 |
increases expression |
ISO |
cupric chloride results in increased expression of SLC22A18 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:2,899,691...2,925,246
Ensembl chr11:2,899,721...2,925,246
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
increases expression |
EXP |
cupric chloride results in increased expression of SLC2A1 mRNA |
CTD |
PMID:15741220 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SLC30A1 |
solute carrier family 30 member 1 |
increases expression |
EXP |
cupric chloride results in increased expression of SLC30A1 mRNA |
CTD |
PMID:24343273 |
|
NCBI chr 1:211,571,568...211,579,161
Ensembl chr 1:211,571,568...211,579,161
|
|
G |
SLC31A1 |
solute carrier family 31 member 1 |
decreases expression multiple interactions |
ISO EXP |
cupric chloride results in decreased expression of SLC31A1 protein SLC31A1 protein results in increased susceptibility to [cupric chloride results in increased abundance of Copper] |
CTD |
PMID:24316150 PMID:24800945 PMID:32278528 |
|
NCBI chr 9:113,221,544...113,264,492
Ensembl chr 9:113,221,544...113,264,492
|
|
G |
SNCA |
synuclein alpha |
affects folding |
EXP |
cupric chloride affects the folding of SNCA protein |
CTD |
PMID:11553618 |
|
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions decreases activity decreases expression increases response to substance |
EXP ISO |
Carnosine inhibits the reaction [cupric chloride results in decreased activity of SOD1 protein]; cupric chloride promotes the reaction [COMMD1 protein binds to SOD1 protein]; Pyruvic Acid inhibits the reaction [SOD1 protein mutant form promotes the reaction [cupric chloride results in increased abundance of Peroxides]]; Pyruvic Acid inhibits the reaction [SOD1 protein mutant form results in increased susceptibility to cupric chloride]; SOD1 protein mutant form promotes the reaction [cupric chloride results in increased abundance of Peroxides] cupric chloride results in decreased expression of SOD1 protein |
CTD |
PMID:15812313 PMID:24691167 PMID:29617964 PMID:32745495 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SORBS1 |
sorbin and SH3 domain containing 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of SORBS1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr10:95,311,773...95,561,371
Ensembl chr10:95,311,771...95,561,414
|
|
G |
SPSB1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
increases expression |
EXP |
cupric chloride results in increased expression of SPSB1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:9,292,894...9,369,532
Ensembl chr 1:9,292,894...9,369,532
|
|
G |
SQLE |
squalene epoxidase |
decreases expression |
EXP |
cupric chloride results in decreased expression of SQLE mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
|
|
G |
SQSTM1 |
sequestosome 1 |
increases expression multiple interactions |
EXP ISO |
cupric chloride results in increased expression of SQSTM1 mRNA Acetylcysteine inhibits the reaction [cupric chloride results in increased expression of SQSTM1 protein]; PP242 inhibits the reaction [cupric chloride results in increased expression of SQSTM1 protein] |
CTD |
PMID:17211630 PMID:23313662 PMID:32512069 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SREBF2 |
sterol regulatory element binding transcription factor 2 |
decreases expression |
EXP |
cupric chloride results in decreased expression of SREBF2 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,079...41,907,307
|
|
G |
ST6GAL1 |
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of ST6GAL1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:186,930,526...187,078,553
Ensembl chr 3:186,930,325...187,078,553
|
|
G |
STARD4 |
StAR related lipid transfer domain containing 4 |
decreases expression |
EXP |
cupric chloride results in decreased expression of STARD4 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 5:111,496,033...111,512,535
Ensembl chr 5:111,496,033...111,512,590
|
|
G |
STAU1 |
staufen double-stranded RNA binding protein 1 |
decreases expression |
EXP |
cupric chloride results in decreased expression of STAU mRNA |
CTD |
PMID:17211630 |
|
NCBI chr20:49,113,339...49,219,295
Ensembl chr20:49,113,339...49,188,367
|
|
G |
STMN1 |
stathmin 1 |
decreases expression |
ISO |
cupric chloride results in decreased expression of STMN1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
|
|
G |
SYN2 |
synapsin II |
decreases expression |
ISO |
cupric chloride results in decreased expression of SYN2 protein |
CTD |
PMID:29617964 |
|
NCBI chr 3:12,004,388...12,192,032
Ensembl chr 3:12,004,388...12,192,032
|
|
G |
TAF7L |
TATA-box binding protein associated factor 7 like |
increases expression |
EXP |
cupric chloride results in increased expression of TAF7L mRNA |
CTD |
PMID:17211630 |
|
NCBI chr X:101,268,257...101,293,083
Ensembl chr X:101,268,253...101,293,057
|
|
G |
TALDO1 |
transaldolase 1 |
increases expression |
EXP |
cupric chloride results in increased expression of TALDO1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:747,464...765,012
Ensembl chr11:747,415...765,012
|
|
G |
TARDBP |
TAR DNA binding protein |
multiple interactions |
EXP |
cupric chloride inhibits the reaction [Paraquat affects the localization of TARDBP protein] |
CTD |
PMID:22879928 |
|
NCBI chr 1:11,012,654...11,030,528
Ensembl chr 1:11,012,344...11,030,528
|
|
G |
TFDP2 |
transcription factor Dp-2 |
affects expression |
EXP |
cupric chloride affects the expression of TFDP2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:141,944,428...142,149,544
Ensembl chr 3:141,944,428...142,149,544
|
|
G |
TFEB |
transcription factor EB |
decreases expression multiple interactions |
ISO |
cupric chloride results in decreased expression of TFEB mRNA; cupric chloride results in decreased expression of TFEB protein PP242 inhibits the reaction [cupric chloride results in decreased expression of TFEB protein] |
CTD |
PMID:32512069 |
|
NCBI chr 6:41,683,978...41,736,223
Ensembl chr 6:41,683,978...41,736,259
|
|
G |
TKT |
transketolase |
increases expression |
EXP |
cupric chloride results in increased expression of TKT mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
|
|
G |
TMED2 |
transmembrane p24 trafficking protein 2 |
decreases expression |
EXP |
cupric chloride results in decreased expression of TMED2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:123,584,552...123,598,582
Ensembl chr12:123,584,533...123,598,582
|
|
G |
TMEM97 |
transmembrane protein 97 |
decreases expression |
EXP |
cupric chloride results in decreased expression of TMEM97 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685
|
|
G |
TNF |
tumor necrosis factor |
increases secretion multiple interactions increases expression |
EXP ISO |
cupric chloride results in increased secretion of TNF protein 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [cupric chloride results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [cupric chloride results in increased secretion of TNF protein]; SC 514 inhibits the reaction [cupric chloride results in increased secretion of TNF protein] cupric chloride inhibits the reaction [TNF protein results in increased secretion of IL6 protein] cupric chloride results in increased expression of TNF protein |
CTD |
PMID:22954531 PMID:23285694 PMID:23313662 PMID:24170445 PMID:24530511 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
affects expression multiple interactions decreases expression increases expression |
ISO EXP |
cupric chloride affects the expression of TRP53 mRNA [cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein; CAT protein inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]; Ethanol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]; Mannitol inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]; neocuproine inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein]; Thiourea inhibits the reaction [[cupric chloride co-treated with di(2-picolyl)amine-3(bromoacetyl)coumarin] results in increased expression of TP53 protein] cupric chloride results in decreased expression of TRP53 protein cupric chloride results in increased expression of TRP53 protein |
CTD |
PMID:23313662 PMID:24170445 PMID:29803612 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
|
|
G |
TP73 |
tumor protein p73 |
affects expression increases expression |
ISO |
cupric chloride affects the expression of TRP73 protein cupric chloride results in increased expression of TRP73 protein |
CTD |
PMID:23313662 PMID:24170445 |
|
NCBI chr 1:3,652,516...3,736,201
Ensembl chr 1:3,652,516...3,736,201
|
|
G |
TPM1 |
tropomyosin 1 |
increases expression |
ISO |
cupric chloride results in increased expression of TPM1 protein |
CTD |
PMID:29617964 |
|
NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,632...63,071,915
|
|
G |
TPPP |
tubulin polymerization promoting protein |
increases expression |
ISO |
cupric chloride results in increased expression of TPPP protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:659,862...700,727
Ensembl chr 5:659,862...693,352
|
|
G |
TRAF5 |
TNF receptor associated factor 5 |
increases expression |
EXP |
cupric chloride results in increased expression of TRAF5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:211,326,635...211,374,946
Ensembl chr 1:211,326,615...211,374,946
|
|
G |
TRIB3 |
tribbles pseudokinase 3 |
increases expression |
EXP |
cupric chloride results in increased expression of TRIB3 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
|
|
G |
TSC22D3 |
TSC22 domain family member 3 |
multiple interactions |
ISO |
[cupric chloride results in increased abundance of Copper] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] |
CTD |
PMID:29957541 |
|
NCBI chr X:107,713,221...107,775,988
Ensembl chr X:107,713,221...107,777,342
|
|
G |
TXN |
thioredoxin |
increases expression |
EXP |
cupric chloride results in increased expression of TXN mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
|
|
G |
TXNL1 |
thioredoxin like 1 |
increases expression |
EXP |
cupric chloride results in increased expression of TXNL1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr18:56,597,209...56,638,592
Ensembl chr18:56,597,209...56,651,600
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
increases expression |
EXP |
cupric chloride results in increased expression of TXNRD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
|
|
G |
TYR |
tyrosinase |
multiple interactions |
EXP |
cupric chloride inhibits the reaction [bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]] |
CTD |
PMID:11092760 |
|
NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
|
|
G |
UBA1 |
ubiquitin like modifier activating enzyme 1 |
multiple interactions |
EXP |
cupric chloride promotes the reaction [Dimethyldithiocarbamate results in decreased activity of and results in decreased ubiquitination of UBA1 protein]; cupric chloride results in decreased activity of and results in decreased ubiquitination of UBA1 protein |
CTD |
PMID:25714994 |
|
NCBI chr X:47,190,847...47,215,128
Ensembl chr X:47,190,861...47,215,128
|
|
G |
UBC |
ubiquitin C |
increases expression |
EXP |
cupric chloride results in increased expression of UBC mRNA |
CTD |
PMID:17211630 |
|
NCBI chr12:124,911,646...124,914,650
Ensembl chr12:124,911,604...124,917,368
|
|
G |
UBR5 |
ubiquitin protein ligase E3 component n-recognin 5 |
increases expression |
EXP |
cupric chloride results in increased expression of UBR5 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:102,252,273...102,412,700
Ensembl chr 8:102,252,273...102,412,759
|
|
G |
UCHL1 |
ubiquitin C-terminal hydrolase L1 |
increases expression |
ISO |
cupric chloride results in increased expression of UCHL1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
|
|
G |
UFD1 |
ubiquitin recognition factor in ER associated degradation 1 |
increases expression |
EXP |
cupric chloride results in increased expression of UFD1 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr22:19,449,911...19,479,193
Ensembl chr22:19,449,911...19,479,202
|
|
G |
UNC79 |
unc-79 homolog, NALCN channel complex subunit |
decreases expression |
EXP |
cupric chloride results in decreased expression of UNC79 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr14:93,333,182...93,707,876
Ensembl chr14:93,333,219...93,707,876
|
|
G |
UNKL |
unk like zinc finger |
increases expression |
EXP |
cupric chloride results in increased expression of UNKL mRNA |
CTD |
PMID:17211630 |
|
NCBI chr16:1,363,205...1,414,704
Ensembl chr16:1,363,205...1,414,751
|
|
G |
UQCRC1 |
ubiquinol-cytochrome c reductase core protein 1 |
increases expression |
ISO |
cupric chloride results in increased expression of UQCRC1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 3:48,599,002...48,609,646
Ensembl chr 3:48,599,002...48,610,976
|
|
G |
UQCRH |
ubiquinol-cytochrome c reductase hinge protein |
decreases expression |
ISO |
cupric chloride results in decreased expression of UQCRH protein |
CTD |
PMID:29617964 |
|
NCBI chr 1:46,303,698...46,316,776
Ensembl chr 1:46,303,698...46,316,776
|
|
G |
UTP11 |
UTP11 small subunit processome component |
increases expression |
EXP |
cupric chloride results in increased expression of UTP11 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 1:38,012,734...38,024,820
Ensembl chr 1:38,009,258...38,024,820
|
|
G |
VDAC1 |
voltage dependent anion channel 1 |
increases expression |
ISO |
cupric chloride results in increased expression of VDAC1 protein |
CTD |
PMID:29617964 |
|
NCBI chr 5:133,971,871...134,114,540
Ensembl chr 5:133,971,871...134,004,975
|
|
G |
VDAC2 |
voltage dependent anion channel 2 |
increases expression |
ISO |
cupric chloride results in increased expression of VDAC2 protein |
CTD |
PMID:29617964 |
|
NCBI chr10:75,210,170...75,231,448
Ensembl chr10:75,210,154...75,231,448
|
|
G |
VEGFA |
vascular endothelial growth factor A |
increases expression |
EXP |
cupric chloride results in increased expression of VEGFA mRNA |
CTD |
PMID:15741220 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
G |
VPS13B |
vacuolar protein sorting 13 homolog B |
affects expression |
EXP |
cupric chloride affects the expression of VPS13B mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 8:99,013,274...99,877,580
Ensembl chr 8:99,013,266...99,877,580
|
|
G |
WDR74 |
WD repeat domain 74 |
affects expression |
EXP |
cupric chloride affects the expression of WDR74 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:62,832,905...62,841,809
Ensembl chr11:62,832,342...62,841,809
|
|
G |
ZBTB5 |
zinc finger and BTB domain containing 5 |
decreases expression |
EXP |
cupric chloride results in decreased expression of ZBTB5 mRNA |
CTD |
PMID:34921933 |
|
NCBI chr 9:37,438,102...37,465,450
Ensembl chr 9:37,438,102...37,465,450
|
|
G |
ZNF12 |
zinc finger protein 12 |
increases expression |
EXP |
cupric chloride results in increased expression of ZNF12 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 7:6,688,433...6,706,947
Ensembl chr 7:6,688,433...6,706,947
|
|
G |
ZNF197 |
zinc finger protein 197 |
affects expression |
EXP |
cupric chloride affects the expression of ZNF197 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 3:44,625,036...44,648,471
Ensembl chr 3:44,584,888...44,648,471
|
|
G |
ZNRD2 |
zinc ribbon domain containing 2 |
increases expression |
EXP |
cupric chloride results in increased expression of ZNRD2 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr11:65,570,477...65,571,888
Ensembl chr11:65,570,460...65,573,942
|
|
G |
ZSWIM6 |
zinc finger SWIM-type containing 6 |
affects expression |
EXP |
cupric chloride affects the expression of ZSWIM6 mRNA |
CTD |
PMID:17211630 |
|
NCBI chr 5:61,332,258...61,546,172
Ensembl chr 5:61,332,258...61,546,172
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases activity |
EXP |
Trifluoperazine results in increased activity of ABCB1 protein |
CTD |
PMID:2900677 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ACHE |
acetylcholinesterase (Cartwright blood group) |
multiple interactions increases activity decreases expression |
ISO |
energostim inhibits the reaction [Trifluoperazine results in decreased expression of ACHE protein] Trifluoperazine results in increased activity of ACHE protein |
CTD |
PMID:15232633 PMID:29614332 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of AKT1 protein]; Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of AKT1 protein] |
CTD |
PMID:19233221 PMID:21544200 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
ATP6V1H |
ATPase H+ transporting V1 subunit H |
multiple interactions |
EXP |
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA |
CTD |
PMID:28366621 |
|
NCBI chr 8:53,715,543...53,843,245
Ensembl chr 8:53,715,543...53,843,558
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
Trifluoperazine results in increased expression of BAX protein |
CTD |
PMID:21475906 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression |
EXP |
Trifluoperazine results in decreased expression of BCL2 protein |
CTD |
PMID:21475906 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CAMK2A |
calcium/calmodulin dependent protein kinase II alpha |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of CAMK2A protein] |
CTD |
PMID:19233221 |
|
NCBI chr 5:150,219,491...150,290,130
Ensembl chr 5:150,219,491...150,290,093
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
ISO EXP |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased cleavage of and results in increased activity of CASP3 protein] |
CTD |
PMID:21544200 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CD44 |
CD44 molecule (Indian blood group) |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD44 protein] |
CTD |
PMID:9929743 |
|
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
|
|
G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:21544200 |
|
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
|
|
G |
FMO2 |
flavin containing dimethylaniline monoxygenase 2 |
increases oxidation |
EXP |
FMO2 protein results in increased oxidation of Trifluoperazine |
CTD |
PMID:26062974 |
|
NCBI chr 1:171,185,208...171,212,686
Ensembl chr 1:171,185,249...171,212,686
|
|
G |
GABBR1 |
gamma-aminobutyric acid type B receptor subunit 1 |
multiple interactions |
EXP |
Trifluoperazine inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] |
CTD |
PMID:15627515 |
|
NCBI chr 6:29,602,238...29,633,183
Ensembl chr 6:29,555,629...29,633,976
|
|
G |
GABBR2 |
gamma-aminobutyric acid type B receptor subunit 2 |
multiple interactions |
EXP |
Trifluoperazine inhibits the reaction [2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABBR1 protein binds to GABBR2 protein]]] |
CTD |
PMID:15627515 |
|
NCBI chr 9:98,288,109...98,708,935
Ensembl chr 9:98,288,109...98,708,935
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
decreases expression |
EXP |
Trifluoperazine results in decreased expression of HIF1A protein |
CTD |
PMID:18822394 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
IL12B |
interleukin 12B |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Hydrogen Peroxide results in decreased expression of IL12B protein] |
CTD |
PMID:16249388 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
KCNH2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
EXP |
Trifluoperazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:21158687 |
|
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
|
|
G |
KCNN2 |
potassium calcium-activated channel subfamily N member 2 |
decreases activity |
ISO |
Trifluoperazine results in decreased activity of KCNN2 protein |
CTD |
PMID:10915830 |
|
NCBI chr 5:114,055,978...114,496,496
Ensembl chr 5:114,055,926...114,496,500
|
|
G |
LAMP1 |
lysosomal associated membrane protein 1 |
multiple interactions |
EXP |
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA |
CTD |
PMID:28366621 |
|
NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO EXP |
Trifluoperazine inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of MAPK1 protein]; Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Trifluoperazine inhibits the reaction [Dinoprost results in increased activity of MAPK1 protein] |
CTD |
PMID:11914123 PMID:21544200 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK14 protein] |
CTD |
PMID:21544200 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO EXP |
Trifluoperazine inhibits the reaction [[Norepinephrine co-treated with Timolol] results in increased activity of MAPK3 protein]; Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Trifluoperazine inhibits the reaction [Dinoprost results in increased activity of MAPK3 protein] |
CTD |
PMID:11914123 PMID:21544200 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK8 protein] |
CTD |
PMID:21544200 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
multiple interactions |
EXP ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] |
CTD |
PMID:21544200 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MT1A |
metallothionein 1A |
increases expression |
ISO |
Trifluoperazine results in increased expression of MT1A mRNA |
CTD |
PMID:8128501 |
|
NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MTOR protein] |
CTD |
PMID:21544200 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
MYL9 |
myosin light chain 9 |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MYL9 protein]; Trifluoperazine inhibits the reaction [Ionomycin results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:19233221 |
|
NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447
|
|
G |
NEFL |
neurofilament light chain |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] |
CTD |
PMID:31969611 |
|
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
|
|
G |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
decreases activity |
ISO |
Trifluoperazine results in decreased activity of NR3C1 protein |
CTD |
PMID:7887964 |
|
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions |
ISO EXP |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased cleavage of PARP1 protein] |
CTD |
PMID:21544200 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PINK1 |
PTEN induced kinase 1 |
multiple interactions |
EXP |
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]] |
CTD |
PMID:28366621 |
|
NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
|
|
G |
PRKN |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions affects localization |
EXP |
PRKN protein affects the reaction [Trifluoperazine affects the localization of PRKN protein] |
CTD |
PMID:28366621 |
|
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
|
|
G |
PRL |
prolactin |
increases expression |
EXP |
Trifluoperazine results in increased expression of PRL protein |
CTD |
PMID:2136057 |
|
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
|
|
G |
REL |
REL proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Hydrogen Peroxide results in decreased localization of REL protein] |
CTD |
PMID:16249388 |
|
NCBI chr 2:60,881,574...60,931,612
Ensembl chr 2:60,881,491...60,931,612
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:21544200 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
SLC5A6 |
solute carrier family 5 member 6 |
multiple interactions |
EXP |
Trifluoperazine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin] |
CTD |
PMID:15561972 |
|
NCBI chr 2:27,199,587...27,212,787
Ensembl chr 2:27,199,587...27,212,958
|
|
G |
TFEB |
transcription factor EB |
multiple interactions |
EXP |
[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]] |
CTD |
PMID:28366621 |
|
NCBI chr 6:41,683,978...41,736,223
Ensembl chr 6:41,683,978...41,736,259
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
decreases activity |
ISO |
Trifluoperazine results in decreased activity of TNFSF11 |
CTD |
PMID:21869564 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
UGT1A4 |
UDP glucuronosyltransferase family 1 member A4 |
multiple interactions increases activity increases glucuronidation |
EXP |
Finasteride inhibits the reaction [UGT1A4 protein results in increased glucuronidation of Trifluoperazine]; hecogenin inhibits the reaction [UGT1A4 protein results in increased glucuronidation of Trifluoperazine]; licochalcone A inhibits the reaction [Trifluoperazine results in increased activity of UGT1A4 protein]; Trifluoperazine inhibits the reaction [UGT1A4 protein results in increased glucuronidation of afloqualone] |
CTD |
PMID:15135306 PMID:15475412 PMID:25393417 PMID:25448279 PMID:26875642 PMID:33290829 More...
|
|
NCBI chr 2:233,718,736...233,773,300
Ensembl chr 2:233,718,736...233,773,300
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
multiple interactions |
EXP ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ABCB1 mRNA] zinc chloride inhibits the reaction [Doxorubicin results in increased expression of ABCB1 mRNA] |
CTD |
PMID:19714248 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCB6 |
ATP binding cassette subfamily B member 6 (Langereis blood group) |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ABCB6 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 2:219,209,772...219,218,958
Ensembl chr 2:219,209,772...219,218,994
|
|
G |
ACHE |
acetylcholinesterase (Cartwright blood group) |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of ACHE protein]; zinc chloride inhibits the reaction [Malathion results in decreased activity of ACHE protein] |
CTD |
PMID:19429256 PMID:29233033 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ACO2 |
aconitase 2 |
multiple interactions |
EXP |
[Citric Acid co-treated with zinc chloride] results in decreased activity of ACO2 protein |
CTD |
PMID:16624386 |
|
NCBI chr22:41,469,117...41,528,974
Ensembl chr22:41,447,830...41,529,273
|
|
G |
ACTB |
actin beta |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of ACTB mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
|
|
G |
ADAM2 |
ADAM metallopeptidase domain 2 |
decreases expression |
EXP |
zinc chloride results in decreased expression of ADAM2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 8:39,743,735...39,838,227
Ensembl chr 8:39,743,735...39,838,227
|
|
G |
ADGRE1 |
adhesion G protein-coupled receptor E1 |
multiple interactions increases expression |
ISO |
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein] |
CTD |
PMID:18509044 |
|
NCBI chr19:6,887,579...6,940,450
Ensembl chr19:6,887,566...6,940,459
|
|
G |
ADM |
adrenomedullin |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ADM mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
|
|
G |
ADORA1 |
adenosine A1 receptor |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [N(6)-cyclohexyladenosine binds to ADORA1 protein] |
CTD |
PMID:10413299 |
|
NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
|
|
G |
AFP |
alpha fetoprotein |
decreases expression |
EXP |
zinc chloride results in decreased expression of AFP mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
|
|
G |
AGO2 |
argonaute RISC catalytic component 2 |
multiple interactions |
EXP |
[Clioquinol co-treated with zinc chloride] results in decreased expression of AGO2 mRNA; [Clioquinol co-treated with zinc chloride] results in decreased expression of AGO2 protein |
CTD |
PMID:22415087 |
|
NCBI chr 8:140,520,156...140,642,313
Ensembl chr 8:140,520,156...140,635,633
|
|
G |
AK4 |
adenylate kinase 4 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of AK4 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 1:65,147,552...65,232,145
Ensembl chr 1:65,147,549...65,232,145
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
ISO |
zinc chloride results in increased phosphorylation of AKT1 protein wortmannin inhibits the reaction [zinc chloride results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:11340092 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
ALAD |
aminolevulinate dehydratase |
multiple interactions |
ISO EXP |
[zinc chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]] which affects the abundance of Mercury; zinc chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein] lead nitrate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]]; triethyllead acetate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]]; zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein] zinc chloride inhibits the reaction [Mercuric Chloride results in decreased activity of ALAD protein]; zinc chloride inhibits the reaction [Mercuric Chloride results in increased activity of ALAD protein] |
CTD |
PMID:2061546 PMID:14615064 PMID:22413763 PMID:24619859 PMID:24679358 |
|
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
|
|
G |
ALDOA |
aldolase, fructose-bisphosphate A |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOA mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
|
|
G |
ALDOC |
aldolase, fructose-bisphosphate C |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOC mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
multiple interactions increases activity |
ISO |
[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of ALPL mRNA zinc chloride results in increased activity of ALPL protein Cadmium inhibits the reaction [zinc chloride results in increased activity of ALPL protein]; zinc chloride inhibits the reaction [Cadmium results in decreased activity of ALPL protein] |
CTD |
PMID:19913120 PMID:26214600 |
|
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
|
|
G |
ANG |
angiogenin |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANG mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
|
|
G |
ANGPTL4 |
angiopoietin like 4 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANGPTL4 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
|
|
G |
ANKRD37 |
ankyrin repeat domain 37 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANKRD37 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628
|
|
G |
ANKZF1 |
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ANKZF1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 2:219,229,806...219,236,679
Ensembl chr 2:219,229,783...219,236,679
|
|
G |
AR |
androgen receptor |
multiple interactions |
ISO |
Androgens inhibits the reaction [zinc chloride inhibits the reaction [Androgens binds to AR protein]]; Dithiothreitol inhibits the reaction [zinc chloride inhibits the reaction [Androgens binds to AR protein]]; zinc chloride inhibits the reaction [Androgens binds to AR protein] |
CTD |
PMID:6323860 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ARG2 |
arginase 2 |
increases expression |
EXP |
zinc chloride results in increased expression of ARG2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
|
|
G |
ARRB2 |
arrestin beta 2 |
affects localization |
EXP |
zinc chloride affects the localization of ARRB2 protein |
CTD |
PMID:16959833 |
|
NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499
|
|
G |
ATF2 |
activating transcription factor 2 |
multiple interactions |
ISO |
[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of ATF2 protein; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:30768131 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
ATF4 |
activating transcription factor 4 |
decreases expression |
EXP |
zinc chloride results in decreased expression of ATF4 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
|
|
G |
ATP6V1B2 |
ATPase H+ transporting V1 subunit B2 |
decreases expression |
EXP |
zinc chloride results in decreased expression of ATP6V1B2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 8:20,197,381...20,221,696
Ensembl chr 8:20,197,381...20,226,819
|
|
G |
ATP7B |
ATPase copper transporting beta |
decreases expression increases expression |
EXP |
zinc chloride results in decreased expression of ATP7B mRNA zinc chloride results in increased expression of ATP7B mRNA |
CTD |
PMID:18947441 |
|
NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,125
|
|
G |
BAG3 |
BAG cochaperone 3 |
increases expression multiple interactions |
EXP |
zinc chloride results in increased expression of BAG3 mRNA zinc chloride results in increased expression of and affects the localization of BAG3 protein |
CTD |
PMID:12706811 PMID:16870260 |
|
NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP ISO |
[Citric Acid co-treated with zinc chloride] results in increased expression of BAX protein zinc chloride promotes the reaction [Doxorubicin results in increased expression of BAX mRNA] zinc chloride affects the reaction [Cadmium Chloride results in increased expression of BAX protein] |
CTD |
PMID:16624386 PMID:19714248 PMID:28390674 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BBC3 |
BCL2 binding component 3 |
multiple interactions |
ISO |
zinc chloride promotes the reaction [Doxorubicin results in increased expression of BBC3 mRNA] |
CTD |
PMID:19714248 |
|
NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP ISO |
[Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2 protein; zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 mRNA]; zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 protein]; zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BCL2 mRNA] zinc chloride inhibits the reaction [Doxorubicin results in increased expression of BCL2 mRNA] |
CTD |
PMID:16624386 PMID:17786326 PMID:19714248 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2A1 |
BCL2 related protein A1 |
increases expression |
EXP |
zinc chloride results in increased expression of BCL2A1 mRNA |
CTD |
PMID:21540303 |
|
NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions |
EXP |
[Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2L1 protein |
CTD |
PMID:16624386 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BDNF |
brain derived neurotrophic factor |
multiple interactions |
ISO |
zinc chloride affects the reaction [Cadmium Chloride affects the expression of BDNF mRNA] |
CTD |
PMID:29548726 |
|
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
multiple interactions |
ISO |
[zinc chloride co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased expression of BGLAP mRNA; [zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of BGLAP mRNA |
CTD |
PMID:19913120 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
BHLHE40 |
basic helix-loop-helix family member e40 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BHLHE40 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,979,437...4,985,323
|
|
G |
BNIP3L |
BCL2 interacting protein 3 like |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BNIP3L mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 8:26,383,054...26,413,127
Ensembl chr 8:26,383,054...26,505,636
|
|
G |
BOP1 |
BOP1 ribosomal biogenesis factor |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BOP1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 8:144,262,045...144,291,438
Ensembl chr 8:144,262,045...144,291,438
|
|
G |
C3 |
complement C3 |
increases expression |
EXP |
zinc chloride results in increased expression of C3 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
CA13 |
carbonic anhydrase 13 |
increases expression |
ISO |
zinc chloride results in increased expression of CAR13 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 8:85,245,458...85,284,073
Ensembl chr 8:85,220,587...85,284,073
|
|
G |
CA9 |
carbonic anhydrase 9 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CA9 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 9:35,673,928...35,681,159
Ensembl chr 9:35,673,928...35,681,159
|
|
G |
CACNA1H |
calcium voltage-gated channel subunit alpha1 H |
decreases activity multiple interactions |
ISO |
zinc chloride results in decreased activity of CACNA1H protein zinc chloride inhibits the reaction [Vincristine results in increased expression of CACNA1H protein] |
CTD |
PMID:34286406 |
|
NCBI chr16:1,153,106...1,221,768
Ensembl chr16:1,153,106...1,221,771
|
|
G |
CALD1 |
caldesmon 1 |
increases expression |
EXP |
zinc chloride results in increased expression of CALD1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 7:134,745,467...134,970,729
Ensembl chr 7:134,744,252...134,970,729
|
|
G |
CASP12 |
caspase 12 (gene/pseudogene) |
multiple interactions |
EXP |
[Citric Acid co-treated with zinc chloride] results in increased activity of CASP12 protein |
CTD |
PMID:16624386 |
|
NCBI chr11:104,885,718...104,898,460
Ensembl chr11:104,885,718...104,898,670
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
[Citric Acid co-treated with zinc chloride] results in increased activity of CASP3 protein |
CTD |
PMID:16624386 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of CASP9 mRNA] |
CTD |
PMID:28390674 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions increases expression increases activity |
ISO EXP |
zinc chloride inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; zinc chloride inhibits the reaction [Malathion results in decreased activity of CAT protein] zinc chloride results in increased expression of CAT mRNA zinc chloride results in increased activity of CAT protein |
CTD |
PMID:9330853 PMID:19429256 PMID:23726800 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCDC102B |
coiled-coil domain containing 102B |
increases expression |
EXP |
zinc chloride results in increased expression of CCDC102B mRNA |
CTD |
PMID:16870260 |
|
NCBI chr18:68,715,216...69,058,121
Ensembl chr18:68,715,209...69,055,189
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
increases expression |
EXP |
zinc chloride results in increased expression of CCL11 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
|
|
G |
CCL15 |
C-C motif chemokine ligand 15 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CCL15 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr17:35,997,582...36,001,553
Ensembl chr17:35,996,440...36,001,553
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CCL17 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
|
|
G |
CCL19 |
C-C motif chemokine ligand 19 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CCL19 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 9:34,689,570...34,691,276
Ensembl chr 9:34,689,570...34,691,276
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
increases expression |
EXP |
zinc chloride results in increased expression of CCL20 mRNA |
CTD |
PMID:19428942 PMID:21540303 PMID:27427241 |
|
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
|
|
G |
CCL24 |
C-C motif chemokine ligand 24 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CCL24 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 7:75,810,825...75,823,372
Ensembl chr 7:75,810,825...75,823,356
|
|
G |
CCL26 |
C-C motif chemokine ligand 26 |
increases expression |
EXP |
zinc chloride results in increased expression of CCL26 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896
|
|
G |
CCNB1 |
cyclin B1 |
increases expression |
ISO |
zinc chloride results in increased expression of CCNB1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCNG1 |
cyclin G1 |
multiple interactions |
ISO |
zinc chloride affects the reaction [Cadmium Chloride results in increased expression of CCNG1 mRNA] |
CTD |
PMID:16842966 |
|
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
|
|
G |
CCNG2 |
cyclin G2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CCNG2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
|
|
G |
CCR6 |
C-C motif chemokine receptor 6 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CCR6 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 6:167,111,795...167,139,141
Ensembl chr 6:167,111,807...167,139,141
|
|
G |
CCR8 |
C-C motif chemokine receptor 8 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CCR8 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 3:39,329,709...39,333,680
Ensembl chr 3:39,329,709...39,333,680
|
|
G |
CD86 |
CD86 molecule |
decreases expression |
ISO |
zinc chloride results in decreased expression of CD86 protein |
CTD |
PMID:24284788 |
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CD9 |
CD9 molecule |
increases expression |
EXP |
zinc chloride results in increased expression of CD9 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
|
|
G |
CDH17 |
cadherin 17 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CDH17 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 8:94,127,162...94,217,278
Ensembl chr 8:94,127,162...94,217,303
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
EXP |
[Citric Acid co-treated with zinc chloride] results in increased expression of CDKN1A protein |
CTD |
PMID:16624386 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
decreases expression |
EXP |
zinc chloride results in decreased expression of CDKN1B mRNA |
CTD |
PMID:21540303 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN2B |
cyclin dependent kinase inhibitor 2B |
decreases expression |
EXP |
zinc chloride results in decreased expression of CDKN2B mRNA |
CTD |
PMID:21540303 |
|
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
|
|
G |
CDR1 |
cerebellar degeneration related 1 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CDR1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr X:140,772,083...140,793,212
Ensembl chr X:140,783,578...140,784,366
|
|
G |
CEACAM6 |
CEA cell adhesion molecule 6 |
increases expression |
EXP |
zinc chloride results in increased expression of CEACAM6 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr19:41,755,530...41,772,211
Ensembl chr19:41,750,977...41,772,211
|
|
G |
CFTR |
CF transmembrane conductance regulator |
increases expression |
EXP |
zinc chloride results in increased expression of CFTR mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
|
|
G |
CHEK1 |
checkpoint kinase 1 |
increases expression |
ISO |
zinc chloride results in increased expression of CHEK1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr11:125,625,136...125,681,124
Ensembl chr11:125,625,163...125,676,255
|
|
G |
CITED2 |
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CITED2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of COL1A1 mRNA |
CTD |
PMID:19913120 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COMMD1 |
copper metabolism domain containing 1 |
multiple interactions |
ISO |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK2 protein; [COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK3 protein |
CTD |
PMID:25007851 |
|
NCBI chr 2:61,888,391...62,136,058
Ensembl chr 2:61,888,724...62,147,247
|
|
G |
COX17 |
cytochrome c oxidase copper chaperone COX17 |
decreases expression |
EXP |
zinc chloride results in decreased expression of COX17 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 3:119,663,975...119,677,406
Ensembl chr 3:119,654,513...119,677,454
|
|
G |
CP |
ceruloplasmin |
increases expression |
EXP |
zinc chloride results in increased expression of CP mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
|
|
G |
CPS1 |
carbamoyl-phosphate synthase 1 |
increases expression |
EXP |
zinc chloride results in increased expression of CPS1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107
|
|
G |
CRP |
C-reactive protein |
increases expression |
EXP |
zinc chloride results in increased expression of CRP mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CSF2 |
colony stimulating factor 2 |
increases expression multiple interactions |
EXP ISO |
zinc chloride results in increased expression of CSF2 mRNA zinc chloride results in increased expression of CSF2 protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein] |
CTD |
PMID:18509044 PMID:21540303 PMID:27427241 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CSRP2 |
cysteine and glycine rich protein 2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CSRP2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr12:76,858,709...76,879,019
Ensembl chr12:76,858,709...76,879,023
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
increases expression |
EXP |
zinc chloride results in increased expression of CXCL1 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
increases expression |
EXP |
zinc chloride results in increased expression of CXCL11 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
|
|
G |
CXCL13 |
C-X-C motif chemokine ligand 13 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CXCL13 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 4:77,511,753...77,611,834
Ensembl chr 4:77,511,753...77,611,834
|
|
G |
CXCL14 |
C-X-C motif chemokine ligand 14 |
increases expression |
EXP |
zinc chloride results in increased expression of CXCL14 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279
|
|
G |
CXCL5 |
C-X-C motif chemokine ligand 5 |
increases expression |
EXP |
zinc chloride results in increased expression of CXCL5 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
|
|
G |
CXCL6 |
C-X-C motif chemokine ligand 6 |
decreases expression |
EXP |
zinc chloride results in decreased expression of CXCL6 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression multiple interactions increases secretion |
EXP |
zinc chloride results in increased expression of CXCL8 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased secretion of CXCL8 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [zinc chloride results in increased secretion of CXCL8 protein]; Acetylcysteine inhibits the reaction [zinc chloride results in increased secretion of CXCL8 protein]; DUOX1 protein affects the reaction [zinc chloride results in increased secretion of CXCL8 protein]; pyrazolanthrone inhibits the reaction [zinc chloride results in increased secretion of CXCL8 protein]; RELA protein affects the reaction [zinc chloride results in increased secretion of CXCL8 protein]; Thiourea inhibits the reaction [zinc chloride results in increased secretion of CXCL8 protein] |
CTD |
PMID:19428942 PMID:21540303 PMID:21842098 PMID:23692033 PMID:27427241 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases stability multiple interactions |
ISO |
zinc chloride results in increased stability of CYP1A1 mRNA; zinc chloride results in increased stability of CYP1A1 protein zinc chloride inhibits the reaction [1,10-phenanthroline inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]] |
CTD |
PMID:19896525 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
DCP1B |
decapping mRNA 1B |
multiple interactions |
EXP |
[Clioquinol co-treated with zinc chloride] results in decreased expression of DCP1B mRNA |
CTD |
PMID:22415087 |
|
NCBI chr12:1,941,591...2,004,457
Ensembl chr12:1,946,053...2,004,535
|
|
G |
DDX21 |
DExD-box helicase 21 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of DDX21 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr10:68,956,170...68,985,068
Ensembl chr10:68,956,135...68,985,068
|
|
G |
DENND2B |
DENN domain containing 2B |
increases expression |
EXP |
zinc chloride results in increased expression of DENND2B mRNA |
CTD |
PMID:16870260 |
|
NCBI chr11:8,693,352...8,910,951
Ensembl chr11:8,693,351...8,910,951
|
|
G |
DHRS2 |
dehydrogenase/reductase 2 |
increases expression |
EXP |
zinc chloride results in increased expression of DHRS2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr14:23,630,115...23,645,639
Ensembl chr14:23,630,115...23,645,639
|
|
G |
DICER1 |
dicer 1, ribonuclease III |
multiple interactions |
EXP |
[Clioquinol co-treated with zinc chloride] results in decreased expression of DICER1 protein |
CTD |
PMID:22415087 |
|
NCBI chr14:95,086,228...95,158,010
Ensembl chr14:95,086,228...95,158,010
|
|
G |
DLL4 |
delta like canonical Notch ligand 4 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in decreased expression of DLL4 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr15:40,929,340...40,939,073
Ensembl chr15:40,929,340...40,939,073
|
|
G |
DRD1 |
dopamine receptor D1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [ecopipam binds to DRD1 protein]; zinc chloride inhibits the reaction [SCH 23390 binds to DRD1 protein] |
CTD |
PMID:9109525 |
|
NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
|
|
G |
DRD2 |
dopamine receptor D2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [3-N-methylspiperone binds to DRD2 protein]; zinc chloride inhibits the reaction [Haloperidol binds to DRD2 protein] |
CTD |
PMID:9109525 |
|
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
|
|
G |
DROSHA |
drosha ribonuclease III |
multiple interactions |
EXP |
[Clioquinol co-treated with zinc chloride] affects the expression of DROSHA protein |
CTD |
PMID:22415087 |
|
NCBI chr 5:31,400,494...31,532,093
Ensembl chr 5:31,400,494...31,532,196
|
|
G |
DUOX1 |
dual oxidase 1 |
multiple interactions |
EXP |
DUOX1 protein affects the reaction [zinc chloride results in increased secretion of CXCL8 protein] |
CTD |
PMID:27427241 |
|
NCBI chr15:45,129,994...45,165,574
Ensembl chr15:45,129,933...45,165,576
|
|
G |
EGFR |
epidermal growth factor receptor |
increases phosphorylation |
EXP |
zinc chloride results in increased phosphorylation of EGFR protein |
CTD |
PMID:21540303 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGLN1 |
egl-9 family hypoxia inducible factor 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of EGLN1 mRNA]; zinc chloride inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of EGLN1 protein] |
CTD |
PMID:16579968 PMID:22202117 |
|
NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287
|
|
G |
EIF4E |
eukaryotic translation initiation factor 4E |
multiple interactions |
EXP |
[Clioquinol co-treated with zinc chloride] results in increased expression of EIF4E mRNA; [Clioquinol co-treated with zinc chloride] results in increased expression of EIF4E protein |
CTD |
PMID:22415087 |
|
NCBI chr 4:98,879,276...98,929,133
Ensembl chr 4:98,879,276...98,929,133
|
|
G |
ELK1 |
ETS transcription factor ELK1 |
multiple interactions increases activity |
ISO |
zinc chloride results in increased phosphorylation of and results in increased activity of ELK1 protein zinc chloride results in increased activity of ELK1 protein |
CTD |
PMID:16960431 PMID:20412391 |
|
NCBI chr X:47,635,520...47,650,604
Ensembl chr X:47,635,521...47,650,604
|
|
G |
ENO2 |
enolase 2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ENO2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
|
|
G |
EPO |
erythropoietin |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of EPO protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] |
CTD |
PMID:11090055 |
|
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
|
|
G |
F2RL2 |
coagulation factor II thrombin receptor like 2 |
decreases expression |
EXP |
zinc chloride results in decreased expression of F2RL2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 5:76,615,482...76,623,403
Ensembl chr 5:76,615,482...76,623,413
|
|
G |
FABP1 |
fatty acid binding protein 1 |
decreases expression |
EXP |
zinc chloride results in decreased expression of FABP1 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
|
|
G |
FAM162A |
family with sequence similarity 162 member A |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of FAM162A mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 3:122,384,182...122,412,334
Ensembl chr 3:122,384,161...122,412,334
|
|
G |
FASN |
fatty acid synthase |
decreases expression |
EXP |
zinc chloride results in decreased expression of FASN mRNA |
CTD |
PMID:21540303 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of FOS mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FOSL1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
zinc chloride results in increased expression of FOSL1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
|
|
G |
FOXA2 |
forkhead box A2 |
decreases expression |
EXP |
zinc chloride results in decreased expression of FOXA2 mRNA |
CTD |
PMID:21540303 |
|
NCBI chr20:22,580,998...22,585,490
Ensembl chr20:22,580,998...22,585,455
|
|
G |
FOXD1 |
forkhead box D1 |
increases expression |
EXP |
zinc chloride results in increased expression of FOXD1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 5:73,446,266...73,448,777
Ensembl chr 5:73,444,827...73,448,777
|
|
G |
G6PC1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Mercuric Chloride results in increased activity of G6PC1 protein] |
CTD |
PMID:22413763 |
|
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
|
|
G |
G6PD |
glucose-6-phosphate dehydrogenase |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein] |
CTD |
PMID:18972399 |
|
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
increases expression |
EXP |
zinc chloride results in increased expression of GADD45A mRNA |
CTD |
PMID:33645215 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GBE1 |
1,4-alpha-glucan branching enzyme 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of GBE1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 3:81,489,703...81,761,645
Ensembl chr 3:81,489,703...81,761,645
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
multiple interactions increases expression |
EXP |
zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLC mRNA] zinc chloride results in increased expression of GCLC mRNA |
CTD |
PMID:18385089 PMID:33645215 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
multiple interactions |
EXP |
zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLM mRNA] |
CTD |
PMID:18385089 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GJA1 |
gap junction protein alpha 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Vincristine results in increased expression of GJA1 protein] |
CTD |
PMID:34286406 |
|
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
|
|
G |
GPX2 |
glutathione peroxidase 2 |
increases expression |
EXP |
zinc chloride results in increased expression of GPX2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
|
|
G |
GRIK2 |
glutamate ionotropic receptor kainate type subunit 2 |
increases expression |
EXP |
zinc chloride results in increased expression of GRIK2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 6:101,393,708...102,070,083
Ensembl chr 6:100,962,701...102,081,622
|
|
G |
GRIN2A |
glutamate ionotropic receptor NMDA type subunit 2A |
multiple interactions |
ISO |
AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of GRIN2A protein]; zinc chloride results in increased expression of and results in increased phosphorylation of GRIN2A protein |
CTD |
PMID:12211081 |
|
NCBI chr16:9,753,404...10,182,908
Ensembl chr16:9,753,404...10,182,928
|
|
G |
GRIN2B |
glutamate ionotropic receptor NMDA type subunit 2B |
multiple interactions |
ISO |
AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of GRIN2B protein]; zinc chloride results in increased expression of and results in increased phosphorylation of GRIN2B protein |
CTD |
PMID:12211081 |
|
NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002
|
|
G |
GRM5 |
glutamate metabotropic receptor 5 |
multiple interactions increases expression |
ISO |
Copper inhibits the reaction [zinc chloride results in increased expression of GRM5 protein] |
CTD |
PMID:25007851 |
|
NCBI chr11:88,504,642...89,065,982
Ensembl chr11:88,504,576...89,065,982
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
EXP ISO |
[Carmustine results in decreased activity of GSR protein] which results in increased susceptibility to zinc chloride zinc chloride inhibits the reaction [Cadmium Chloride results in increased activity of GSR protein]; zinc chloride inhibits the reaction [Copper results in decreased activity of GSR protein]; zinc chloride inhibits the reaction [Malathion results in decreased activity of GSR protein] |
CTD |
PMID:12632252 PMID:19429256 PMID:20600438 PMID:23726800 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
[Cadmium Chloride co-treated with zinc chloride] results in increased expression of GSTP1 protein |
CTD |
PMID:15602745 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
GYS1 |
glycogen synthase 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of GYS1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr19:48,968,130...48,993,309
Ensembl chr19:48,968,130...48,993,310
|
|
G |
H2AX |
H2A.X variant histone |
increases expression |
EXP |
zinc chloride results in increased expression of H2AX mRNA |
CTD |
PMID:18947441 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
HCFC1R1 |
host cell factor C1 regulator 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HCFC1R1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr16:3,022,620...3,024,286
Ensembl chr16:3,022,625...3,024,286
|
|
G |
HDAC1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in decreased expression of HDAC1 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
|
|
G |
HELLS |
helicase, lymphoid specific |
increases expression |
ISO |
zinc chloride results in increased expression of HELLS mRNA |
CTD |
PMID:19000923 |
|
NCBI chr10:94,545,788...94,613,905
Ensembl chr10:94,545,329...94,613,905
|
|
G |
HEPH |
hephaestin |
decreases expression |
EXP |
zinc chloride results in decreased expression of HEPH mRNA |
CTD |
PMID:18947441 |
|
NCBI chr X:66,162,671...66,268,863
Ensembl chr X:66,162,671...66,268,867
|
|
G |
HEXB |
hexosaminidase subunit beta |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [2-phenylphenol results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [bitertanol results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [Butylated Hydroxyanisole results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [Butylated Hydroxytoluene results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [butylparaben results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [EPN oxon results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [Permethrin results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [prothiophos results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [pyridaben results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [salinomycin results in increased secretion of HEXB protein]; zinc chloride inhibits the reaction [terbufos results in increased secretion of HEXB protein] |
CTD |
PMID:15272608 |
|
NCBI chr 5:74,640,023...74,721,288
Ensembl chr 5:74,640,023...74,722,647
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
multiple interactions affects splicing increases expression |
EXP ISO |
Cycloheximide inhibits the reaction [zinc chloride results in increased expression of HIF1A protein alternative form]; zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [HIPK2 protein binds to HIF1A promoter]]]; zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; zinc chloride inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased stability of and results in increased expression of HIF1A protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] zinc chloride affects the splicing of HIF1A mRNA zinc chloride results in increased expression of HIF1A mRNA; zinc chloride results in increased expression of HIF1A mRNA alternative form; zinc chloride results in increased expression of HIF1A protein alternative form [Doxorubicin co-treated with zinc chloride] results in decreased expression of HIF1A mRNA |
CTD |
PMID:11090055 PMID:11739637 PMID:16579968 PMID:19714248 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HILPDA |
hypoxia inducible lipid droplet associated |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HILPDA mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418
|
|
G |
HIPK2 |
homeodomain interacting protein kinase 2 |
multiple interactions |
EXP ISO |
zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin promotes the reaction [HIPK2 protein binds to HIF1A promoter]]]; zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of HIPK2 protein]; zinc chloride inhibits the reaction [Oxygen deficiency results in decreased expression of HIPK2 protein] [Doxorubicin co-treated with zinc chloride] results in increased expression of HIPK2 mRNA |
CTD |
PMID:19714248 |
|
NCBI chr 7:139,561,570...139,777,998
Ensembl chr 7:139,561,570...139,777,998
|
|
G |
HK2 |
hexokinase 2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HK2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression multiple interactions |
EXP ISO |
zinc chloride results in increased expression of HMOX1 mRNA; zinc chloride results in increased expression of HMOX1 protein zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of HMOX1 mRNA] HMOX1 enhancer affects the reaction [zinc chloride results in increased expression of HMOX1 mRNA] |
CTD |
PMID:7538129 PMID:16870260 PMID:22202117 PMID:27427241 PMID:33645215 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HSP90AA2P |
heat shock protein 90 alpha family class A member 2, pseudogene |
increases expression |
EXP |
zinc chloride results in increased expression of HSP90AA2P mRNA |
CTD |
PMID:21540303 |
|
NCBI chr11:27,888,171...27,891,092
Ensembl chr11:27,888,838...27,891,033
|
|
G |
HSPA1A |
heat shock protein family A (Hsp70) member 1A |
increases expression |
EXP ISO |
zinc chloride results in increased expression of HSPA1A mRNA |
CTD |
PMID:12085988 PMID:16870260 |
|
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
|
|
G |
HSPA1B |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
zinc chloride results in increased expression of HSPA1B mRNA |
CTD |
PMID:12085988 |
|
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
|
|
G |
HSPA6 |
heat shock protein family A (Hsp70) member 6 |
increases expression |
EXP |
zinc chloride results in increased expression of HSPA6 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
|
|
G |
HSPD1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
ISO |
zinc chloride results in increased expression of HSPD1 protein |
CTD |
PMID:19429256 |
|
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
|
|
G |
IFNA2 |
interferon alpha 2 |
decreases expression |
EXP |
zinc chloride results in decreased expression of IFNA2 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in decreased expression of IFNG mRNA; zinc chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]] |
CTD |
PMID:8975779 PMID:31588059 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases expression |
EXP |
zinc chloride results in decreased expression of IKBKB mRNA |
CTD |
PMID:21540303 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
IL10 |
interleukin 10 |
increases expression |
ISO |
zinc chloride results in increased expression of IL10 mRNA |
CTD |
PMID:24284788 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL10RB |
interleukin 10 receptor subunit beta |
decreases expression |
EXP |
zinc chloride results in decreased expression of IL10RB mRNA |
CTD |
PMID:19428942 |
|
NCBI chr21:33,266,367...33,310,182
Ensembl chr21:33,266,367...33,311,420
|
|
G |
IL12B |
interleukin 12B |
decreases expression |
ISO |
zinc chloride results in decreased expression of IL12B mRNA |
CTD |
PMID:24284788 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL18R1 |
interleukin 18 receptor 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of IL18R1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 2:102,355,796...102,398,776
Ensembl chr 2:102,311,529...102,398,777
|
|
G |
IL1A |
interleukin 1 alpha |
increases expression multiple interactions |
ISO |
zinc chloride results in increased expression of IL1A protein N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of IL1A protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1A protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1A protein] |
CTD |
PMID:18509044 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions increases expression |
ISO EXP |
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; zinc chloride inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased secretion of IL1B protein]] zinc chloride inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] zinc chloride results in increased expression of IL1B mRNA |
CTD |
PMID:9138684 PMID:18509044 PMID:19130485 PMID:27427241 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1RL1 |
interleukin 1 receptor like 1 |
increases expression |
ISO |
zinc chloride results in increased expression of IL1RL1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
increases expression |
EXP |
zinc chloride results in increased expression of IL1RN mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL3 |
interleukin 3 |
multiple interactions increases expression |
ISO |
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of IL3 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL3 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL3 protein] |
CTD |
PMID:18509044 |
|
NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
|
|
G |
IL36RN |
interleukin 36 receptor antagonist |
decreases expression |
EXP |
zinc chloride results in decreased expression of IL36RN mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 2:113,058,638...113,064,744
Ensembl chr 2:113,058,638...113,065,382
|
|
G |
IL37 |
interleukin 37 |
decreases expression |
EXP |
zinc chloride results in decreased expression of IL37 mRNA |
CTD |
PMID:19428942 |
|
NCBI chr 2:112,911,165...112,918,882
Ensembl chr 2:112,911,165...112,918,882
|
|
G |
IL6 |
interleukin 6 |
increases secretion multiple interactions increases expression |
EXP |
zinc chloride results in increased secretion of IL6 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased secretion of IL6 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [zinc chloride results in increased secretion of IL6 protein]; Acetylcysteine inhibits the reaction [zinc chloride results in increased secretion of IL6 protein]; RELA protein affects the reaction [zinc chloride results in increased secretion of IL6 protein]; Thiourea inhibits the reaction [zinc chloride results in increased secretion of IL6 protein] zinc chloride results in increased expression of IL6 mRNA |
CTD |
PMID:21842098 PMID:27427241 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INSIG2 |
insulin induced gene 2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of INSIG2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 2:118,088,471...118,110,997
Ensembl chr 2:118,088,452...118,110,997
|
|
G |
INSR |
insulin receptor |
increases phosphorylation |
ISO |
zinc chloride results in increased phosphorylation of INSR protein |
CTD |
PMID:11340092 |
|
NCBI chr19:7,112,265...7,294,414
Ensembl chr19:7,112,255...7,294,414
|
|
G |
IREB2 |
iron responsive element binding protein 2 |
increases expression |
EXP |
zinc chloride results in increased expression of IREB2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr15:78,437,431...78,501,453
Ensembl chr15:78,437,431...78,501,453
|
|
G |
ITGB6 |
integrin subunit beta 6 |
increases expression |
EXP |
zinc chloride results in increased expression of ITGB6 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 2:160,099,671...160,200,272
Ensembl chr 2:160,099,667...160,200,313
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP ISO |
zinc chloride results in increased expression of JUN mRNA [[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of JUN protein; Acetylcysteine inhibits the reaction [zinc chloride results in increased expression of JUN mRNA]; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of JUN protein] |
CTD |
PMID:11306679 PMID:19000923 PMID:21540303 PMID:30768131 PMID:33645215 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
JUNB |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
zinc chloride results in increased expression of JUNB mRNA |
CTD |
PMID:19000923 |
|
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
|
|
G |
KAT5 |
lysine acetyltransferase 5 |
multiple interactions |
EXP |
zinc chloride affects the reaction [4-aminophenylarsenoxide binds to KAT5 protein] |
CTD |
PMID:28837777 |
|
NCBI chr11:65,712,018...65,719,604
Ensembl chr11:65,711,996...65,719,604
|
|
G |
KDM3A |
lysine demethylase 3A |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of KDM3A mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716
|
|
G |
KDM4B |
lysine demethylase 4B |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of KDM4B mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr19:4,969,113...5,153,598
Ensembl chr19:4,969,113...5,153,598
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
affects folding multiple interactions |
ISO |
zinc chloride affects the folding of KEAP1 protein zinc chloride promotes the reaction [KEAP1 protein binds to KEAP1 protein] |
CTD |
PMID:30261176 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
KIF5A |
kinesin family member 5A |
multiple interactions decreases activity |
EXP |
Adenosine Triphosphate inhibits the reaction [zinc chloride results in decreased activity of KIF5A protein]; Magnesium Chloride affects the reaction [zinc chloride results in decreased activity of KIF5A protein] |
CTD |
PMID:28122263 |
|
NCBI chr12:57,550,044...57,586,633
Ensembl chr12:57,546,026...57,586,633
|
|
G |
LEP |
leptin |
increases expression |
EXP |
zinc chloride results in increased expression of LEP mRNA |
CTD |
PMID:21540303 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LIMCH1 |
LIM and calponin homology domains 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of LIMCH1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:41,359,607...41,700,044
Ensembl chr 4:41,359,607...41,700,044
|
|
G |
LTA |
lymphotoxin alpha |
decreases expression increases expression |
EXP |
zinc chloride results in decreased expression of LTA mRNA zinc chloride results in increased expression of LTA mRNA |
CTD |
PMID:19428942 PMID:21540303 |
|
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
|
|
G |
LTB4R |
leukotriene B4 receptor |
decreases expression |
EXP |
zinc chloride results in decreased expression of LTB4R mRNA |
CTD |
PMID:19428942 |
|
NCBI chr14:24,311,502...24,318,036
Ensembl chr14:24,311,450...24,318,036
|
|
G |
MAFF |
MAF bZIP transcription factor F |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of MAFF mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
|
|
G |
MAFG |
MAF bZIP transcription factor G |
increases expression |
EXP |
zinc chloride results in increased expression of MAFG mRNA |
CTD |
PMID:11162468 |
|
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
|
|
G |
MAML1 |
mastermind like transcriptional coactivator 1 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of MAML1 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 5:179,732,822...179,777,283
Ensembl chr 5:179,732,822...179,777,283
|
|
G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
increases activity |
ISO |
zinc chloride results in increased activity of MAP2K4 protein |
CTD |
PMID:11306679 |
|
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
|
|
G |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1 |
multiple interactions increases activity |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased activity of MAP3K1 protein]; PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAP3K1 protein] |
CTD |
PMID:11306679 |
|
NCBI chr 5:56,815,549...56,896,152
Ensembl chr 5:56,815,549...56,896,152
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases activity increases phosphorylation |
ISO |
N,N'-diphenyl-4-phenylenediamine inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK1 protein]; zinc chloride results in increased phosphorylation of and results in increased activity of MAPK1 protein zinc chloride results in increased activity of MAPK1 protein |
CTD |
PMID:11306679 PMID:11551972 PMID:16960431 PMID:20412391 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
1,3-dimethylthiourea inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; Go 6976 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; manumycin inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; N,N'-diphenyl-4-phenylenediamine inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; Vanadates promotes the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein]; zinc chloride results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:16960431 PMID:20412391 PMID:21575692 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased activity of MAPK8 protein]; [[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of MAPK8 protein; Acetylcysteine inhibits the reaction [zinc chloride results in increased activity of MAPK8 protein]; PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAPK8 protein]; pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [zinc chloride results in increased abundance of Zinc]] results in increased phosphorylation of MAPK8 protein]; RAC1 protein affects the reaction [zinc chloride results in increased activity of MAPK8 protein]; zinc chloride inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK8 protein]; zinc chloride results in increased phosphorylation of and results in increased activity of MAPK8 protein |
CTD |
PMID:11306679 PMID:20423716 PMID:30768131 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:20423716 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MCM3 |
minichromosome maintenance complex component 3 |
increases expression |
ISO |
zinc chloride results in increased expression of MCM3 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 6:52,264,015...52,284,742
Ensembl chr 6:52,264,014...52,284,881
|
|
G |
MIF |
macrophage migration inhibitory factor |
decreases expression |
EXP |
zinc chloride results in decreased expression of MIF mRNA |
CTD |
PMID:18947441 |
|
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
|
|
G |
MIR130A |
microRNA 130a |
multiple interactions |
EXP |
[Clioquinol co-treated with zinc chloride] results in decreased expression of MIR130A mRNA |
CTD |
PMID:22415087 |
|
NCBI chr11:57,641,198...57,641,286
Ensembl chr11:57,641,198...57,641,286
|
|
G |
MIR15A |
microRNA 15a |
multiple interactions |
EXP |
[Clioquinol co-treated with zinc chloride] results in decreased expression of MIR15A mRNA |
CTD |
PMID:22415087 |
|
NCBI chr13:50,049,119...50,049,201
Ensembl chr13:50,049,119...50,049,201
|
|
G |
MIR223 |
microRNA 223 |
multiple interactions |
EXP |
[Clioquinol co-treated with zinc chloride] results in decreased expression of MIR223 mRNA |
CTD |
PMID:22415087 |
|
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
|
|
G |
MIR29A |
microRNA 29a |
multiple interactions |
EXP |
[Clioquinol co-treated with zinc chloride] results in decreased expression of MIR29A mRNA |
CTD |
PMID:22415087 |
|
NCBI chr 7:130,876,747...130,876,810
Ensembl chr 7:130,876,747...130,876,810
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Ellagic Acid results in decreased activity of and results in decreased secretion of MMP2 protein] |
CTD |
PMID:21573219 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP7 |
matrix metallopeptidase 7 |
decreases expression |
EXP |
zinc chloride results in decreased expression of MMP7 mRNA |
CTD |
PMID:21540303 |
|
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
|
|
G |
MT1A |
metallothionein 1A |
increases expression multiple interactions |
ISO |
zinc chloride results in increased expression of MT1A mRNA; zinc chloride results in increased expression of MT1A protein zinc chloride promotes the reaction [Glucose results in increased expression of MT1A mRNA] |
CTD |
PMID:8928928 PMID:17637929 PMID:23056475 |
|
NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087
|
|
G |
MT1E |
metallothionein 1E |
increases expression |
EXP |
zinc chloride results in increased expression of MT1E mRNA |
CTD |
PMID:16870260 |
|
NCBI chr16:56,625,781...56,627,112
Ensembl chr16:56,625,475...56,627,112
|
|
G |
MT1F |
metallothionein 1F |
increases expression |
EXP |
zinc chloride results in increased expression of MT1F mRNA |
CTD |
PMID:16870260 |
|
NCBI chr16:56,657,959...56,659,303
Ensembl chr16:56,657,731...56,660,698
|
|
G |
MT1G |
metallothionein 1G |
increases expression |
EXP |
zinc chloride results in increased expression of MT1G mRNA |
CTD |
PMID:16870260 |
|
NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,730...56,668,065
|
|
G |
MT1H |
metallothionein 1H |
increases expression |
EXP |
zinc chloride results in increased expression of MT1H mRNA |
CTD |
PMID:16870260 PMID:18947441 |
|
NCBI chr16:56,669,814...56,671,129
Ensembl chr16:56,669,814...56,671,129
|
|
G |
MT1HL1 |
metallothionein 1H like 1 |
increases expression |
EXP |
zinc chloride results in increased expression of MT1HL1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 1:237,004,103...237,004,441
Ensembl chr 1:237,004,103...237,004,441
|
|
G |
MT1L |
metallothionein 1L, pseudogene |
increases expression |
EXP |
zinc chloride results in increased expression of MT1L mRNA |
CTD |
PMID:16870260 |
|
NCBI chr16:56,617,461...56,618,818
Ensembl chr16:56,617,563...56,618,680
|
|
G |
MT1M |
metallothionein 1M |
increases expression |
EXP |
zinc chloride results in increased expression of MT1M mRNA |
CTD |
PMID:16870260 |
|
NCBI chr16:56,632,659...56,633,981
Ensembl chr16:56,632,659...56,633,981
|
|
G |
MT1X |
metallothionein 1X |
multiple interactions increases expression affects response to substance decreases expression affects binding |
EXP ISO |
epigallocatechin gallate inhibits the reaction [zinc chloride results in increased expression of MT1X mRNA]; Grape Seed Proanthocyanidins inhibits the reaction [zinc chloride results in increased expression of MT1X mRNA] zinc chloride results in increased expression of MT1 mRNA; zinc chloride results in increased expression of MT1 protein MT1 affects the susceptibility to zinc chloride zinc chloride results in decreased expression of MT1 protein zinc chloride binds to MT1 protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]; bisindolylmaleimide I inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]; Dicumarol inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]; Edetic Acid inhibits the reaction [zinc chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA]]; Genistein inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]; Ro 31-8220 inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]; Sodium Selenite inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]; Wortmannin inhibits the reaction [zinc chloride results in increased expression of MT1 mRNA]; zinc chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of MT1 mRNA] |
CTD |
PMID:3422486 PMID:11551972 PMID:14998373 PMID:15288509 PMID:16870260 PMID:16987576 PMID:17637929 PMID:17910954 PMID:19835899 PMID:20471814 PMID:24284788 PMID:33645215 More...
|
|
NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
|
|
G |
MT2A |
metallothionein 2A |
multiple interactions increases expression affects binding affects response to substance |
EXP ISO |
[zinc chloride co-treated with pyrithione zinc] results in increased expression of MT2A mRNA; Dactinomycin inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA]; epigallocatechin gallate inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA]; Grape Seed Proanthocyanidins inhibits the reaction [zinc chloride results in increased expression of MT2A mRNA]; zinc chloride inhibits the reaction [Lipopolysaccharides results in increased expression of MT2A mRNA] zinc chloride results in increased expression of MT2A mRNA; zinc chloride results in increased expression of MT2A protein zinc chloride promotes the reaction [Glucose results in increased expression of MT2A mRNA] zinc chloride results in increased expression of MT2 mRNA; zinc chloride results in increased expression of MT2 protein zinc chloride promotes the reaction [Cadmium Chloride results in increased expression of MT2 mRNA] zinc chloride binds to MT2 protein MT2 affects the susceptibility to zinc chloride |
CTD |
PMID:9138684 PMID:15288509 PMID:16842966 PMID:16870260 PMID:16987576 PMID:17234632 PMID:17637929 PMID:18947441 PMID:19835899 PMID:20471814 PMID:20801194 PMID:23056475 PMID:33645215 More...
|
|
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
|
|
G |
MT3 |
metallothionein 3 |
increases expression |
EXP |
zinc chloride results in increased expression of MT3 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr16:56,589,528...56,591,085
Ensembl chr16:56,589,074...56,591,088
|
|
G |
MTA2 |
metastasis associated 1 family member 2 |
decreases expression |
EXP |
zinc chloride results in decreased expression of MTA2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr11:62,593,214...62,601,865
Ensembl chr11:62,593,214...62,601,865
|
|
G |
MTF1 |
metal regulatory transcription factor 1 |
multiple interactions affects localization decreases expression |
ISO EXP |
zinc chloride results in increased phosphorylation of and results in increased activity of MTF1 protein zinc chloride affects the localization of MTF1 protein zinc chloride results in decreased expression of MTF1 mRNA |
CTD |
PMID:11551972 PMID:16423564 PMID:18947441 |
|
NCBI chr 1:37,809,574...37,859,592
Ensembl chr 1:37,809,574...37,859,592
|
|
G |
MTF2 |
metal response element binding transcription factor 2 |
decreases expression |
EXP |
zinc chloride results in decreased expression of MTF2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 1:93,079,283...93,139,076
Ensembl chr 1:93,079,235...93,139,079
|
|
G |
NCF1 |
neutrophil cytosolic factor 1 |
multiple interactions increases response to substance |
ISO |
NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1A protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL3 protein] NCF1 results in increased susceptibility to zinc chloride |
CTD |
PMID:18509044 |
|
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
|
|
G |
NDRG1 |
N-myc downstream regulated 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of NDRG1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
|
|
G |
NDUFAF5 |
NADH:ubiquinone oxidoreductase complex assembly factor 5 |
decreases expression |
EXP |
zinc chloride results in decreased expression of NDUFAF5 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr20:13,785,028...13,821,580
Ensembl chr20:13,785,007...13,821,580
|
|
G |
NF2 |
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor |
decreases expression |
EXP |
zinc chloride results in decreased expression of NF2 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr22:29,603,556...29,698,600
Ensembl chr22:29,603,556...29,698,598
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
affects response to substance multiple interactions |
ISO EXP |
[NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to zinc chloride zinc chloride promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein] |
CTD |
PMID:18385089 PMID:19303893 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
increases activity |
EXP |
zinc chloride results in increased activity of NFKB1 protein |
CTD |
PMID:21842098 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NIP7 |
nucleolar pre-rRNA processing protein NIP7 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of NIP7 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr16:69,339,772...69,343,106
Ensembl chr16:69,337,996...69,343,106
|
|
G |
NMNAT1 |
nicotinamide nucleotide adenylyltransferase 1 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of NMNAT1 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr 1:9,942,923...9,996,892
Ensembl chr 1:9,943,428...9,985,501
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]] |
CTD |
PMID:8975779 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOX4 |
NADPH oxidase 4 |
increases expression |
EXP |
zinc chloride results in increased expression of NOX4 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
|
|
G |
NTN3 |
netrin 3 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of NTN3 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr16:2,471,297...2,474,145
Ensembl chr16:2,471,297...2,474,145
|
|
G |
OR2AG2 |
olfactory receptor family 2 subfamily AG member 2 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of OR2AG2 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr11:6,765,626...6,771,976
Ensembl chr11:6,765,626...6,771,976
|
|
G |
OR4C12 |
olfactory receptor family 4 subfamily C member 12 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in decreased expression of OR4C12 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr11:49,981,473...49,982,535
Ensembl chr11:49,981,473...49,982,535
|
|
G |
ORM1 |
orosomucoid 1 |
increases expression |
ISO |
zinc chloride results in increased expression of ORM1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,098...114,326,479
|
|
G |
ORM2 |
orosomucoid 2 |
increases expression |
ISO |
zinc chloride results in increased expression of ORM2 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 9:114,329,869...114,333,251
Ensembl chr 9:114,329,869...114,333,251
|
|
G |
P2RX2 |
purinergic receptor P2X 2 |
multiple interactions |
ISO |
zinc chloride promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein] |
CTD |
PMID:16190872 |
|
NCBI chr12:132,618,776...132,622,388
Ensembl chr12:132,618,776...132,622,388
|
|
G |
P4HA1 |
prolyl 4-hydroxylase subunit alpha 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of P4HA1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr10:73,007,217...73,096,866
Ensembl chr10:73,007,217...73,096,974
|
|
G |
P4HA2 |
prolyl 4-hydroxylase subunit alpha 2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of P4HA2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 5:132,190,147...132,227,853
Ensembl chr 5:132,190,147...132,295,315
|
|
G |
PAIP1 |
poly(A) binding protein interacting protein 1 |
decreases expression |
EXP |
zinc chloride results in decreased expression of PAIP1 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 5:43,526,267...43,557,411
Ensembl chr 5:43,526,267...43,557,758
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions increases expression increases activity increases response to substance |
EXP ISO |
zinc chloride inhibits the reaction [cobaltous chloride inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein]]; zinc chloride inhibits the reaction [sodium arsenite results in decreased activity of PARP1 protein]; zinc chloride promotes the reaction [Hydrogen Peroxide results in increased activity of PARP1 protein] zinc chloride results in increased expression of PARP1 protein zinc chloride results in increased activity of PARP1 protein PARP1 results in increased susceptibility to zinc chloride 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; acetovanillone inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]; Cibacron Blue F 3GA inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; coomassie Brilliant Blue inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]; NCF1 gene mutant form inhibits the reaction [zinc chloride results in increased activity of PARP1 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of ADGRE1 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1A protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL1B protein]; PARP1 gene mutant form inhibits the reaction [zinc chloride results in increased expression of IL3 protein]; periodate-oxidized adenosine 5'-triphosphate inhibits the reaction [zinc chloride results in increased expression of PARP1 protein]; pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid inhibits the reaction [zinc chloride results in increased expression of PARP1 protein] |
CTD |
PMID:18509044 PMID:19056730 PMID:19714248 PMID:22253048 PMID:33645215 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCBD1 |
pterin-4 alpha-carbinolamine dehydratase 1 |
increases expression |
EXP |
zinc chloride results in increased expression of PCBD1 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr10:70,882,280...70,888,565
Ensembl chr10:70,882,280...70,888,565
|
|
G |
PCNA |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
[Cadmium Chloride co-treated with zinc chloride] results in increased expression of PCNA protein |
CTD |
PMID:15602745 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PDAP1 |
PDGFA associated protein 1 |
multiple interactions |
ISO |
zinc chloride promotes the reaction [Cadmium Chloride results in increased expression of PDAP1 mRNA] |
CTD |
PMID:16842966 |
|
NCBI chr 7:99,394,673...99,408,597
Ensembl chr 7:99,392,048...99,408,597
|
|
G |
PDK1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PDK1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 2:172,555,373...172,724,312
Ensembl chr 2:172,555,373...172,608,669
|
|
G |
PEG3 |
paternally expressed 3 |
decreases expression |
EXP |
zinc chloride results in decreased expression of PEG3 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr19:56,810,082...56,840,726
Ensembl chr19:56,810,077...56,840,728
|
|
G |
PFKFB3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PFKFB3 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr10:6,144,921...6,326,637
Ensembl chr10:6,144,934...6,254,644
|
|
G |
PFKFB4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PFKFB4 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 3:48,517,684...48,563,136
Ensembl chr 3:48,517,684...48,562,015
|
|
G |
PGF |
placental growth factor |
increases expression |
EXP |
zinc chloride results in increased expression of PGF mRNA |
CTD |
PMID:16870260 |
|
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
|
|
G |
PGK1 |
phosphoglycerate kinase 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PGK1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr X:78,104,248...78,129,295
Ensembl chr X:77,910,739...78,129,295
|
|
G |
PGM1 |
phosphoglucomutase 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PGM1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 1:63,593,411...63,660,245
Ensembl chr 1:63,593,411...63,660,245
|
|
G |
PHEX |
phosphate regulating endopeptidase X-linked |
increases expression |
ISO |
zinc chloride results in increased expression of PHEX mRNA |
CTD |
PMID:19000923 |
|
NCBI chr X:22,032,325...22,251,310
Ensembl chr X:22,032,325...22,494,713
|
|
G |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
multiple interactions |
ISO |
PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAP3K1 protein]; PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAPK8 protein] |
CTD |
PMID:11306679 |
|
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
|
|
G |
PIK3R4 |
phosphoinositide-3-kinase regulatory subunit 4 |
increases expression |
EXP |
zinc chloride results in increased expression of PIK3R4 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 3:130,678,934...130,746,829
Ensembl chr 3:130,678,934...130,746,829
|
|
G |
PIK3R5 |
phosphoinositide-3-kinase regulatory subunit 5 |
increases expression |
ISO |
zinc chloride results in increased expression of PIK3R5 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr17:8,878,916...8,965,707
Ensembl chr17:8,878,911...8,965,712
|
|
G |
PMP22 |
peripheral myelin protein 22 |
increases expression |
EXP |
zinc chloride results in increased expression of PMP22 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr17:15,229,779...15,265,326
Ensembl chr17:15,229,773...15,272,292
|
|
G |
PRKCA |
protein kinase C alpha |
multiple interactions affects localization |
ISO |
1,3-dimethylthiourea inhibits the reaction [zinc chloride affects the localization of and results in increased activity of PRKCA protein]; 1,3-dimethylthiourea inhibits the reaction [zinc chloride affects the localization of PRKCA protein]; Glucose promotes the reaction [zinc chloride affects the localization of and results in increased activity of PRKCA protein]; Vanadates promotes the reaction [zinc chloride affects the localization of PRKCA protein]; zinc chloride affects the localization of and results in increased activity of PRKCA protein |
CTD |
PMID:20800666 PMID:21575692 |
|
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
|
|
G |
PTH1R |
parathyroid hormone 1 receptor |
multiple interactions |
ISO |
[zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of PTH1R mRNA |
CTD |
PMID:19913120 |
|
NCBI chr 3:46,877,721...46,903,799
Ensembl chr 3:46,877,721...46,903,799
|
|
G |
RAB20 |
RAB20, member RAS oncogene family |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RAB20 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr13:110,523,066...110,561,722
Ensembl chr13:110,523,066...110,561,722
|
|
G |
RAC1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
RAC1 protein affects the reaction [zinc chloride results in increased activity of MAPK8 protein] |
CTD |
PMID:11306679 |
|
NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967
|
|
G |
RAD21 |
RAD21 cohesin complex component |
increases expression |
ISO |
zinc chloride results in increased expression of RAD21 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 8:116,845,934...116,874,776
Ensembl chr 8:116,845,934...116,874,776
|
|
G |
RAD51AP1 |
RAD51 associated protein 1 |
increases expression |
ISO |
zinc chloride results in increased expression of RAD51AP1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr12:4,538,890...4,560,047
Ensembl chr12:4,538,798...4,560,047
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions increases phosphorylation |
ISO |
1,3-dimethylthiourea inhibits the reaction [zinc chloride results in increased phosphorylation of RAF1 protein]; AG 1879 inhibits the reaction [zinc chloride results in increased phosphorylation of RAF1 protein]; Go 6976 inhibits the reaction [zinc chloride results in increased phosphorylation of RAF1 protein]; manumycin inhibits the reaction [zinc chloride results in increased phosphorylation of RAF1 protein] |
CTD |
PMID:21575692 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
|
|
G |
RANGAP1 |
Ran GTPase activating protein 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of RANGAP1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr22:41,244,779...41,302,369
Ensembl chr22:41,244,779...41,286,187
|
|
G |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RBPJ mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131
|
|
G |
RECK |
reversion inducing cysteine rich protein with kazal motifs |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK mRNA]; zinc chloride inhibits the reaction [Ellagic Acid results in increased expression of RECK protein] |
CTD |
PMID:21573219 |
|
NCBI chr 9:36,036,913...36,124,455
Ensembl chr 9:36,036,913...36,124,455
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases phosphorylation |
EXP |
RELA protein affects the reaction [zinc chloride results in increased secretion of CXCL8 protein]; RELA protein affects the reaction [zinc chloride results in increased secretion of IL6 protein] zinc chloride results in increased phosphorylation of RELA protein |
CTD |
PMID:27427241 |
|
NCBI chr11:65,653,601...65,662,916
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RIF1 |
replication timing regulatory factor 1 |
increases expression |
ISO |
zinc chloride results in increased expression of RIF1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr 2:151,409,902...151,534,435
Ensembl chr 2:151,409,883...151,508,013
|
|
G |
RIOK3 |
RIO kinase 3 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RIOK3 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr18:23,453,287...23,483,140
Ensembl chr18:23,453,287...23,486,603
|
|
G |
RORA |
RAR related orphan receptor A |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RORA mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr15:60,488,284...61,229,302
Ensembl chr15:60,488,284...61,229,302
|
|
G |
RPL11 |
ribosomal protein L11 |
decreases expression |
EXP |
zinc chloride results in decreased expression of RPL11 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 1:23,691,779...23,696,835
Ensembl chr 1:23,691,742...23,696,835
|
|
G |
RRP15 |
ribosomal RNA processing 15 homolog |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of RRP15 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 1:218,285,293...218,337,983
Ensembl chr 1:218,285,293...218,337,983
|
|
G |
RRS1 |
ribosome biogenesis regulator 1 homolog |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of RRS1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 8:66,429,014...66,430,733
Ensembl chr 8:66,429,014...66,430,733
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
[zinc chloride co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased expression of RUNX2 protein; [zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of RUNX2 mRNA; [zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of RUNX2 protein |
CTD |
PMID:19913120 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
RUVBL1 |
RuvB like AAA ATPase 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of RUVBL1 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 3:128,064,785...128,153,914
Ensembl chr 3:128,064,778...128,153,914
|
|
G |
SALL1 |
spalt like transcription factor 1 |
multiple interactions |
ISO |
[zinc chloride results in increased abundance of Zinc] which results in increased expression of SALL1 mRNA |
CTD |
PMID:31588059 |
|
NCBI chr16:51,135,982...51,152,334
Ensembl chr16:51,135,982...51,152,334
|
|
G |
SAP30 |
Sin3A associated protein 30 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SAP30 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 4:173,370,954...173,377,532
Ensembl chr 4:173,369,969...173,377,532
|
|
G |
SBNO1 |
strawberry notch homolog 1 |
increases expression |
EXP |
zinc chloride results in increased expression of SBNO1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr12:123,289,109...123,364,847
Ensembl chr12:123,289,109...123,364,847
|
|
G |
SCARA3 |
scavenger receptor class A member 3 |
decreases expression |
EXP |
zinc chloride results in decreased expression of SCARA3 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr 8:27,633,463...27,734,141
Ensembl chr 8:27,633,868...27,676,776
|
|
G |
SCARB1 |
scavenger receptor class B member 1 |
increases expression |
ISO |
zinc chloride results in increased expression of SCARB1 mRNA |
CTD |
PMID:19000923 |
|
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
|
|
G |
SCD |
stearoyl-CoA desaturase |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SCD mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
|
|
G |
SELPLG |
selectin P ligand |
increases expression |
EXP |
zinc chloride results in increased expression of SELPLG mRNA |
CTD |
PMID:21540303 |
|
NCBI chr12:108,621,895...108,633,894
Ensembl chr12:108,621,895...108,633,894
|
|
G |
SERTAD2 |
SERTA domain containing 2 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SERTAD2 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr 2:64,631,621...64,653,913
Ensembl chr 2:64,631,621...64,751,005
|
|
G |
SHANK2 |
SH3 and multiple ankyrin repeat domains 2 |
multiple interactions increases expression |
ISO |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK2 protein; Copper inhibits the reaction [zinc chloride results in increased expression of SHANK2 protein] |
CTD |
PMID:25007851 |
|
NCBI chr11:70,467,854...71,253,228
Ensembl chr11:70,467,854...71,252,577
|
|
G |
SHANK3 |
SH3 and multiple ankyrin repeat domains 3 |
multiple interactions increases expression |
ISO |
[COMMD1 protein co-treated with zinc chloride co-treated with cupric chloride] results in increased expression of SHANK3 protein; Copper inhibits the reaction [zinc chloride results in increased expression of SHANK3 protein] |
CTD |
PMID:25007851 |
|
NCBI chr22:50,672,823...50,733,212
Ensembl chr22:50,674,415...50,733,212
|
|
G |
SLC11A2 |
solute carrier family 11 member 2 |
increases transport |
EXP |
SLC11A2 protein results in increased transport of zinc chloride |
CTD |
PMID:22736759 |
|
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
|
|
G |
SLC16A3 |
solute carrier family 16 member 3 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SLC16A3 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr17:82,217,934...82,240,086
Ensembl chr17:82,217,934...82,261,129
|
|
G |
SLC1A2 |
solute carrier family 1 member 2 |
multiple interactions |
ISO |
[Kainic Acid co-treated with zinc chloride] results in decreased expression of SLC1A2 protein |
CTD |
PMID:19061913 |
|
NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
|
|
G |
SLC1A5 |
solute carrier family 1 member 5 |
decreases expression |
EXP |
zinc chloride results in decreased expression of SLC1A5 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594
|
|
G |
SLC25A15 |
solute carrier family 25 member 15 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of SLC25A15 mRNA] |
CTD |
PMID:22202117 |
|
NCBI chr13:40,789,611...40,812,460
Ensembl chr13:40,789,412...40,812,460
|
|
G |
SLC2A1 |
solute carrier family 2 member 1 |
multiple interactions increases expression |
EXP ISO |
zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of SLC2A1 mRNA] zinc chloride results in increased expression of SLC2A1 mRNA |
CTD |
PMID:19000923 PMID:22202117 |
|
NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893
|
|
G |
SLC30A1 |
solute carrier family 30 member 1 |
multiple interactions increases expression |
EXP ISO |
epigallocatechin gallate inhibits the reaction [zinc chloride results in increased expression of SLC30A1 mRNA]; zinc chloride inhibits the reaction [Grape Seed Proanthocyanidins results in decreased expression of SLC30A1 mRNA] zinc chloride affects the reaction [Cadmium Chloride affects the expression of SLC30A1 mRNA]; zinc chloride promotes the reaction [Glucose results in increased expression of SLC30A1 mRNA] |
CTD |
PMID:18947441 PMID:20392624 PMID:20471814 PMID:23056475 PMID:25653005 PMID:33645215 More...
|
|
NCBI chr 1:211,571,568...211,579,161
Ensembl chr 1:211,571,568...211,579,161
|
|
G |
SLC30A2 |
solute carrier family 30 member 2 |
increases expression multiple interactions |
ISO |
zinc chloride results in increased expression of SLC30A2 mRNA zinc chloride affects the reaction [Cadmium Chloride affects the expression of SLC30A2 mRNA] |
CTD |
PMID:20392624 PMID:25653005 |
|
NCBI chr 1:26,037,252...26,046,118
Ensembl chr 1:26,037,252...26,046,118
|
|
G |
SLC30A4 |
solute carrier family 30 member 4 |
multiple interactions |
ISO |
zinc chloride affects the reaction [Cadmium Chloride affects the expression of SLC30A4 mRNA] |
CTD |
PMID:25653005 |
|
NCBI chr15:45,479,606...45,522,755
Ensembl chr15:45,479,606...45,522,755
|
|
G |
SLC30A5 |
solute carrier family 30 member 5 |
decreases expression multiple interactions |
EXP |
zinc chloride results in decreased expression of SLC30A5 mRNA Dactinomycin inhibits the reaction [zinc chloride results in decreased expression of SLC30A5 mRNA] |
CTD |
PMID:17234632 PMID:20392624 |
|
NCBI chr 5:69,094,014...69,131,069
Ensembl chr 5:69,093,991...69,131,069
|
|
G |
SLC30A7 |
solute carrier family 30 member 7 |
increases expression decreases expression |
EXP |
zinc chloride results in increased expression of SLC30A7 mRNA zinc chloride results in decreased expression of SLC30A7 mRNA |
CTD |
PMID:20392624 |
|
NCBI chr 1:100,896,090...100,996,078
Ensembl chr 1:100,896,076...100,981,757
|
|
G |
SLC31A2 |
solute carrier family 31 member 2 |
increases expression decreases expression |
EXP |
zinc chloride results in increased expression of SLC31A2 mRNA zinc chloride results in decreased expression of SLC31A2 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 9:113,151,007...113,164,140
Ensembl chr 9:113,150,976...113,164,140
|
|
G |
SLC39A1 |
solute carrier family 39 member 1 |
multiple interactions |
EXP |
zinc chloride inhibits the reaction [Grape Seed Proanthocyanidins results in increased expression of SLC39A1 mRNA] |
CTD |
PMID:20471814 |
|
NCBI chr 1:153,959,110...153,968,184
Ensembl chr 1:153,959,099...153,968,184
|
|
G |
SLC39A2 |
solute carrier family 39 member 2 |
multiple interactions increases expression |
EXP |
[SLC39A2 protein co-treated with zinc chloride] results in increased abundance of Glutathione; zinc chloride promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein]; zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLC mRNA]; zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLM mRNA] zinc chloride results in increased expression of SLC39A2 mRNA |
CTD |
PMID:18385089 |
|
NCBI chr14:20,999,293...21,001,871
Ensembl chr14:20,999,255...21,001,871
|
|
G |
SLC39A3 |
solute carrier family 39 member 3 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of SLC39A3 mRNA] |
CTD |
PMID:25653005 |
|
NCBI chr19:2,732,524...2,740,076
Ensembl chr19:2,732,204...2,740,028
|
|
G |
SLC39A4 |
solute carrier family 39 member 4 |
multiple interactions decreases expression |
EXP ISO |
zinc chloride inhibits the reaction [Grape Seed Proanthocyanidins results in increased expression of SLC39A4 mRNA] zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of SLC39A4 mRNA] zinc chloride results in decreased expression of SLC39A4 mRNA |
CTD |
PMID:20471814 PMID:25653005 |
|
NCBI chr 8:144,412,414...144,416,844
Ensembl chr 8:144,409,742...144,416,844
|
|
G |
SLC39A8 |
solute carrier family 39 member 8 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride results in increased expression of SLC39A8 mRNA] |
CTD |
PMID:25653005 |
|
NCBI chr 4:102,251,041...102,345,482
Ensembl chr 4:102,251,080...102,431,258
|
|
G |
SLC48A1 |
solute carrier family 48 member 1 |
increases expression |
EXP |
zinc chloride results in increased expression of SLC48A1 mRNA |
CTD |
PMID:16870260 |
|
NCBI chr12:47,753,934...47,782,751
Ensembl chr12:47,753,916...47,782,751
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride inhibits the reaction [SP1 protein binds to and affects the expression of SLC5A1 promoter]]; zinc chloride inhibits the reaction [Cadmium Chloride results in decreased expression of SLC5A1 mRNA] |
CTD |
PMID:20060848 |
|
NCBI chr22:32,043,261...32,113,029
Ensembl chr22:32,043,261...32,113,029
|
|
G |
SLC5A2 |
solute carrier family 5 member 2 |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride inhibits the reaction [SP110 protein binds to and affects the expression of SLC5A2 promoter]]; zinc chloride inhibits the reaction [Cadmium Chloride results in decreased expression of SLC5A2 mRNA] |
CTD |
PMID:20060848 |
|
NCBI chr16:31,483,123...31,490,769
Ensembl chr16:31,483,002...31,490,860
|
|
G |
SLC9A1 |
solute carrier family 9 member A1 |
increases expression |
EXP |
zinc chloride results in increased expression of SLC9A1 mRNA |
CTD |
PMID:18947441 |
|
NCBI chr 1:27,098,809...27,155,125
Ensembl chr 1:27,098,809...27,166,981
|
|
G |
SORD |
sorbitol dehydrogenase |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride results in decreased activity of SORD protein] |
CTD |
PMID:18972399 |
|
NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185
|
|
G |
SP1 |
Sp1 transcription factor |
multiple interactions increases activity |
ISO EXP |
zinc chloride inhibits the reaction [Cadmium Chloride inhibits the reaction [SP1 protein binds to and affects the expression of SLC5A1 promoter]] zinc chloride results in increased activity of SP1 protein |
CTD |
PMID:9330853 PMID:20060848 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
G |
SP110 |
SP110 nuclear body protein |
multiple interactions |
ISO |
zinc chloride inhibits the reaction [Cadmium Chloride inhibits the reaction [SP110 protein binds to and affects the expression of SLC5A2 promoter]] |
CTD |
PMID:20060848 |
|
NCBI chr 2:230,165,186...230,225,636
Ensembl chr 2:230,165,186...230,225,729
|
|
G |
| |